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VOORWOORD 
Het was slechts mogelijk dit werk uit te voeren en alle in dit 
proefschrift beschreven patienten gegevens te verzamelen, dank zij 
de daadwerkelijke hulp van de assistenten, de verpleegkundigen en de 
chefs de clinique van het SKZ. Ik wens hen dan ook van ganser harte 
te bedanken voor hun inzet. 
Prof. Dr. H.J. Degenhart en Prof. Dr. J. Fernandes hebben mij 
gedurende al die jaren begeleid en ik dank hen voor het 
ononderbroken vertrouwen dat ze mij geschonken hebben. 
John Fernandes heeft steeds blijk gegeven van belangstelling en mij 
van zijn steun verzekerd ondanks zijn zware verplichtingen en het 
feit dat Antwerpen zo ver van Groningen ligt. Hij werkte steeds 
motiverend en aanmoedigend, vooral in de zware beproevingen die ik 
doorgemaakt heb bij het overlijden van mijn vader en door 
persoonlijke gezondheidsproblemen.De hieruit voortkomende vertraging 
werd aanvaard en verwerkt met als motto: wat begonnen is, moet 
klaarkomen. Oprechte dank hiervoor, John .ook Annetje ben ik heel 
wat verschuldigd voor haar gastvrijheid tijdens mijn verblijven in 
Groningen. 
Het is onmogelijk hier te verwoorden, alles wat ik van Herman 
Degenhart geleerd heb. Ik hoop dat ik dit kan bewijzen tijdens mijn 
verdere loopbaan. Gesprekstechnieken en Nederlandse taalwenken, 
inzicht in cijfermateriaal, een grondige benadering van de 
problematiek, heb ik aan hem te danken. Hij heeft mijn schrijfwerk 
kritisch beschouwd en de nodige wenken gegeven voor de onmisbare 
verbeteringen. Voor dit alles ben ik hem ten zeerste dankbaar. 
Beide promotoren konden het waarschijnlijk slechts overleven dank 
zij een stevig gevoel voor humor en relativiteit. 
Het analytisch gedeelte van het onderzoek, tijdrovend en vaak 
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ondankbaar, heb ik te danken aan de volle inzet van Ingrid 
Luijendijk. Ingrid wist een vriendelijke sfeer te creeren die mij 
steeds deed terug keren naar het laboratorium, zelfs na langdurige 
afwezigheden. Hannie de Leeuw-Boon, Anita Korteland-van Male, Nel 
de Kort zal ik niet vergeten. Ik wil er ook aan herinneren dat Hans 
verweyen tijdens zijn studentenjaren als keuze-practicant aan het 
gemeenschappelijk onderzoek heeft gewerkt. Hun volharding liet toe 
alle experimenten tot een goed einde te brengen. 
Dr. M. Sinaasappel en Dr. J. Bouquet, de kindergastroenterologen van 
het SKZ, zijn bereid geweest de patienten op de voet te volgen en de 
protocollen ter beschikking te stellen nadat ik Rotterdam verlaten 
had om terug naar Antwerpen te keren. Beste Maarten en Jan, mijn 
oprechte dank hiervoor. 
Wees ervan verzekerd dat dit proefschrift nooit tot stand gekomen 
was zonder de steun van Prof. Dr. H.K.A. Visser. Hij heeft de deur 
van het SKZ voor mij wijd open gehouden, ook teen ik naar Antwerpen 
vertrokken was. Ik ken ononderbroken gebruik maken van de biblio-
theek en van de diensten van Ellen Nelemans-Van den Broek, van het 
archief en van de audio-visuele dienst dank zij B.R.M. van Royen, L. 
Baars en J.R.M. de Kuyper. Het is onder de leiding van Prof. Dr. 
H.K.A. Visser dat de therapie met zink sulfaat op punt gesteld 
toegepast , geanalyseerd en gevolgd werd. Aan hem ben ik het goede 
einde - eind goed, al goed - verschuldigd en terecht ben ik hem ten 
zeerste dankbaar. 
Het is mij bijzonder aangenaam al diegenen die mij buiten de 
Erasmus Universiteit Rotterdam geholpen hebben, te danken. De 
samenwerking met het Antwerpse team van Prof. Dr. H. Deelstra in 
h.b. Harry Robberecht, Eddy Roeckens en Hilde Lambrechts bleef 
steeds op een heel hoog niveau. De bromatologische studies werden 
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aldaar uitgevoerd. Persoonlijk hoop ik ook, en dit is mijn uitdruk-
kelijke wens, dat de samenwerking met het Algemeen Kinderziekenhuis 
Antwerpen, neg vele jaren zal kunnen voortduren in dezelfde aange-
name en positieve sfeer. 
Prof. Dr. R. Clara, hoofd van de kinderafdeling, was zich terdege 
bewust van het belang van het spoorelementonderzoek. Reeds jaren 
heeft hij zich persoonlijk ingezet om de kinderen uit het Antwerpse 
tegen loodintoxicaties te beschermen.In feite sluit dit proefschrift 
geed aan bij zijn eigen onderzoek 
mijn dankbaarheid vinden. 
Moge hij hier het bewijs van 
De hulp van de isotopen dienst van het I.R.I. te Delft onder de 
64 
leiding van Dr. c.J.A. van den Hamer, voor de CU analyses, werd 
steeds op prijs gesteld. 
Honderden pagina's teksten werden door Ingrid Bracke-van den Bossche 
getypt! en opnieuw getypt! en dan herhaaldelijk verbeterd. Ingrid, 
van harte dank! 
Mrs. Esther Konig heeft mijn Engels op verstandige en vriendelijke 
wijze verbeterd. Esther, tha~~ you for trying. 
11And last but not least" wens ik mijn echtgenoot Bernard-Dominique 
en mijn zoon Darry te danken voor hun geduld en aansporingen "bij 
hoog en bij laag". Hen moet ik ook bedanken voor de crash cursus 
computerkunde, het "Wordstar Processor System" op Kaypro portatief 
model evenals voor de Hewlett-Packard Laser Jet Printer Zender 
deze computer hulp zou dit proefschrift nooit opgesteld geweest 
zijn. 
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CHAPTER ~ GENERAL INTRODUCTION" 
1.1 THE ESSENTIAL~ ELEMENTS 
The trace elements are so called because they constitute less than 
0,01% of the weight of the human body (IUPAC ,1972 ). 
This name is in fact quite arbitrary. It survives from the time when 
early investigators, with the methods then available, were experien-
cing great difficulties in measuring these substances in plant and 
animal tissues. The introduction of new analytical methods,e.g. 
atomic absorption spectrophotometry ,neutron activation and micro-
wave induced emission spectroscopy have resulted in an enormous 
increase in our understanding of the role these elements play in 
metabolism. 
Iron,iodine, zinc, cobalt and copper are ,since years,recognised to 
be essential in man in their absence normal growth, development 
andjor reproduction is impossible. There is now clear evidence that 
selenium, chromium and manganese have also vital functions in human 
metabolism .They should therefore be considered essential too. 
Other elements possibly essential for man include molybdenum (as a 
component of the enzymes xanthine oxidase and sulfite oxidase) , 
nickel, silicon ,lithium and arsenic .The evidence for the 
essentiality of tin and vanadium in animal nutrition is rather weak 
Nielsen,l984). 
Partially published in:Clinical Nutrition 19Sl,R. Wesdorp et P. 
Soeters, (eds), Churchill Livingstone ,N.Y.,l982 . 
The role and function of iron and iodide are well known and beyond 
the scope of this thesis.Selenium,copper and zinc will be discussed 
in section 1.2. 
The only manifestation of chromium deficiency thus far documented in 
the human is an impaired glucose tolerance with fasting hyper-
glycemia, glucosuria, hypercholesterolemia and peripheral neuropathy 
which responded to chromium (Jeejeebhoy ,1977). 
Several glycosyl transferases require manganese for activity. These 
enzymes play an important role in mucopolysaccharide metabolism 
( Shaw, 1980). Manganese is also required for cholesterol synthesis. 
Pyruvate carboxylase is among the manganese metallo-enzymes that 
have been isolated • Although unequivocal evidence of deficiency has 
not been observed in human subjects ,the existence of a deficiency 
syndrome has been convincingly demonstrated in animals.The features 
of manganese deficiency, namely impaired growth, skeletal abnormali-
ties, depressed reproductive function and ataxia in the newborn seem 
to be similar in all species studied • 
The function of cobalt appears to be related to its presence in the 
vitamin B 12 molecule. No additional cobalt is required if the 
intake of this vitamin is adequate (Prasad ,1978 ). 
Fluoride functions as a structural element in osseous and dental 
tissues • In adequate amounts , it prevents the formation of dental 
cavities. There is at this moment no other known indication of a 
biological need (Prasad, 1978). 
1.2 ~ REVIEW OF THE ELEMENTS INVESTIGATED. 
SELENIUM 
In 1957,selenium was recognised to be an essential nutrient for 
animals .Schwarz and Foltz showed that its deficiency in rats leads 
to necrotic degeneration of liver, pancreas, kidney and heart.It 
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was not until 1979 ,that the existence of a human requirement for 
this element was suspected by Van Rij et al. 
For a comprehensive review,the reader is referred to Schwarz 
(1976), Ver1inden (1981), Burk (1983) and Combs (1984). 
Although selenium is found in a muscle protein ,its only well 
characterized and essential biochemical function in mammals is in 
the enzyme glutathione peroxidase .It is known to be subjected to 
cyclic redox changes during its catalytic action .This enzyme has a 
major function in the removal of H o and organic peroxides gene-
2 2 
rated during oxidative metabolism in cells and tissues. Another 
enzyme catalase, can also reduce H 0 
2 2 
but in most cells 
catalase and GSH-Per are separated in different subcellular compart-
ments . While catalase is confined almost exclusively to the peroxi-
somes, GSH-Per is found in the cytosol and mitochondrial matrix 
space .There, it provides an efficient means of defense against the 
build-up of peroxides which otherwise would damage cell membranes 
and macromolecules including DNA ( Rotruck,l973 ; Flohe,l979). 
GSH Per also interacts at 2 sites of the arachidonic acid cas-
cade, preventing the accumulation of prostaglandin G (important for 
the inflammatory response of tissues) and regulating prostacyclin 
biosynthesis .Prostacyclin inhibits the aggregation and adhesion of 
platelets to the endothelial lining of blood vessels (1). Platelets 
of selenium depleted humans show severely diminished activities of 
the enzyme and also altered metabolism in arachidonic acid metabo-
lites (Kasperek,l982 ). Selenium plays also an important role in 
immune functions.In neutrophils, it is necessary for post-phagocytic 
cytotoxicity .Impaired candidacidal activity is an early feature 
in cattle deprived of this element . 
Little is known about the characteristics and the clinical pre-
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sentation of selenium deficiency in ~~e human .The patients des-
cribed by Van Rij have shown tenderness in the thighs and were not 
able to walk.This syndrome responded within a week to selenium 
supplementation given as sole therapy . At the same time, an ende-
mic cardiomyopathy, occurring mainly in infants and children and 
known in China as Keshan disease ,was reported to be prevented with 
supplementation of selenium (Chen,1980). It confirmed the growing 
evidence that selenium might be essential for the function of the 
heart and other muscles in man ( Editorial,l979 Johnson 1981; 
Fleming 1982 ) .This was the rationale for an epidemiological study 
done in Finland (Salonen, 1982) . Reduced serum selenium concentra-
tions ·Proved to be correlated with acute coronary heart disease and 
subsequent cardiovascular death . 
The requirement for selenium can be related to the degree of oxida-
tive stress . It varies also with the supply of nutrients such as 
zinc, copper, manganese ,iron and the other antioxydant,vitamin E. 
Little seems to be known about selenium in human fetal development. 
Birth of a deformed infant and miscarriages in several p~egnancies 
amongst female laboratory technicians exposed to selenium, suggest 
teratogenic potential of selenium among humans (Robertson, 1970). 
On the other hand ,selenium prevents cadmium and arsenic induced 
teratogenesis The symptoms of selenium deficiency and toxicity 
are species related .They are therefore difficult to interpret and 
extrapolate to man. Selenium has first been regarded as a toxic 
substance (Cooper, 1974} .This belief stems principally from the 
well-known selenium poisoning of cattle caused by the consumption of 
seleniferous plants. Paradoxically ,selenium is relatively non toxic 
in man ( Schwarz,l976 ; Civil, l978).According to Schwarz,clear-cut 
cases of selenium toxicity in the human population of the seleni-
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ferous area of the United States have not been found ,in spite of 
careful surveys • It has been used commercially for many years with 
no long-term systemic effect on industrial workers. Inhaled selenium 
dust and fumes have given rise to irritations of the respiratory 
tract .contact with selenium dioxide causes dermatitis and burns. 
Organa-selenium compounds seem to have a wide range of toxicity in 
the laboratory animals studied.Dietary selenium apparently induces 
cancer in rodents.In humans, however, epidemiological evidence sug-
gests that selenium compounds may have a therapeutic value against 
cancer (Schrauzer ,1977). There are at this moment no direct reports 
about selenium carcinogenicity in humans. As for other metals, the 
difference between toxicity and essentiality is not due to the 
nature of the element involved but to the dosis received.The daily 
intake for a adult of 70 Kg varies from 30 to 300 ug 1 day 
according to the country considered.In adults, signs of toxicity 
(gastric problems,liver disease ) occur at intake levels of approxi-
mately 700 ug 1 day. Astronomical intakes ( up to 1 g of selenium) 
have been reported to cause death.Two children with cystic fibrosis 
died after chronic intake of high doses of selenium compounds, 
purchased in health stores ( Hubbard,l980). 
COPPER 
In 1928 Hart et al. showed copper to be an essential nutrient for 
the rat .They speculated upon its possible significance for human 
metabolism .In 1935 ,this was partially documented by Elvehjem when 
he showed that copper could be effective in treating anemic infants. 
For a comprehensive review ,the reader is referred to Shaw (1980) 
and to Danks (1983). 
Copper is now known to be a component of a number of metalloenzymes. 
The major ones are caeruloplasmin, cytochrome C oxidase,superoxide 
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dismutase, lysyl oxidase which catalyses the cross-linking of the 
polypeptide chains of collagen and elastin and finally tyrosinase 
which catalyses the first two steps in the biosynthesis of melanin. 
Copper deficiency is thought to interfere with heme synthesis in 
three ways: a.by diminishing iron transport into the mitochondria, 
b.by decreasing the activity of ferrochelatase, c.possibly by redu-
cing the activity of the copper iron enzyme cytochrome c oxidase. 
Neutropenia and anemia resistant to iron therapy are regular fea-
tures in copper deficient animals and infants (Lardy, 1978) .Later 
on bone changes reminiscent of scurvy may develop with occasional 
fractures. Copper is accumulated in the liver during the latest 
weeks of pregnancy ( Widdowson,l972).?reterm infants weighing less 
than 1200 g are especially at risk , showing deficiencies 3 to 6 
months after birth (Ashkenazi, 1973 ). 
The full blown syndrome of severe copper deficiency is observed in a 
lethal X linked inherited disease first described by Menkes et 
al. (Danks, 1972). There are many of the features of copper defici-
ency ( pili terti, typical bone changes, arterial intimal changes, 
cerebellar degeneration with hypotonia, seizures and developmental 
regression, hypothermia) as observed in the laboratory animal but 
apparently without neutropenia and anemia. Although copper absorp-
tion is altered ,the defect is not limited to transport alone, but 
seems to affect distribution as well (Danks,l977). 
Little seems to be known about the effect of copper 
during human pregnancy Copper must enter the embryo 
deficiency 
from the 
earliest stages of gestation.Copper deficiency during pregnancy in 
sheep results in the ataxic disease 11 Swayback" in the newborn lamb. 
In affected animals there is an extensive demyelination of the CNS. 
The brain mitochondria show a depletion of cytochrome c oxidase. 
6 
These changes are also observed in a number of other species (Hur-
ley,l976). 
With the exception of prematurely born infants fed on TPN and 
elemental diets (Sivasubramanian,l978 ; Heller, 
evidence of copper deficiency is extremely rare . 
seems to be quite low ( Shaw,l982; Wilson, 1960). 
1978) ,nutritional 
Its requirement 
Copper toxicity is well recognized It occurs rather frequently as 
a consequence of massive contamination or as a consequence of 
Wilson's disease 
Copper poisoning,for example,is seen in Indian Childhood Cirrhosis. 
Brass and copper household utensils are the most probable source of 
the gross accumulation of copper in the liver (Tanner,l979 ). 
Wilson's disease ( Wilson,1912) is a autosomically recessive inhe-
rited metabolic disease (prevalence 1 in IOO.OOO live births) .It is 
characterised by a progressive cirrhosis of the liver, proximal 
renal tubular malfunction with glucosuria and aminoaciduria, hepato-
lenticular degeneration,osteoporosis and arthropathy and Kayser-
Fleischer rings in the cornea . This is due to the pathological 
accumulation of copper in the tissues. In Wilson's disease ,both 
biliary excretion of copper in the bile ( Danks,l983) and incorpora-
tion in caeruloplasmin are severely impaired Vierling,l978). The 
basic defect underlying this entity is not yet known.If not adequa-
tely treated ,the disease is fatal. 
ZINC 
In 1869, Raulin showed that zinc is essential for the growth of the 
fungus Aspergillus Niger. It was not until 1934 that Todd et al. 
demonstrated that it was an essential nutrient for a mammalian 
species - the rat .Not until 1963 had Prasad documented the 
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occurrence of zinc deficiency in the human and thus established the 
essentiality of this metal for man.In 1973,Barnes and Moynahan 
recognized the fundamental role of zinc in the pathogenesis of a 
rare inherited disorder :acrodermatitis enteropathica (AE). 
For a comprehensive review,the reader is referred to Aggett(l979) 
Gordon (198l),Hambidge (l98l),Prasad (1983 ,1984). 
The first concrete demonstration of a specific biological function, 
critically dependent on the presence of zinc ,came in 1940. Keilin 
and Mann found that carbonic anhydrase contained zinc that was 
essential to its mechanism of action.If related enzymes from diffe-
rent species are included, more than 200 zinc proteins, most of them 
enzymes, are presently on record (Vallee,l984). 
Zinc is present in the enzymes in a fixed stoichiometric amount and 
its presence is essential to the catalytic function of the enzymes: 
removal of the zinc with chelating agents often leaves an inactive 
apoenzyme but full activity can generally be restored by the addi-
tion of zinc. Three enzymes,alkaline phosphatase,carboxypeptidase 
and thymidine kinase appear to be most sensitive to zinc restric-
tion. It is also established that the DNA - and RNA polymerases and 
reverse transcriptases of numerous prokaryotic and eukaryotic orga-
nisms are zinc enzymes (Lieberman,1963). This explains the essential 
role of zinc in the replication and transcription of DNA during cell 
division. 
Aside of their function as an integral part of a biologically impor-
tant protein, the zinc ions seem to participate in the regulation 
of enzyme activity. Zinc ions,for example, have a specific role in 
modulating cell membrane function probably by antagonizing calcium 
at the calmodulin binding sites {Brewer,l9SO).Recent evidence 
cates that zinc plays a crucial role in immune functions 
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indi-
Chan-
dra,l980): not only does it exert a profound and apparently specific 
effect on the thymus and thymocytes ( Good,l979) but also on granu-
locytes ( Briggs,l982).Abnormal granulocyte chemotaxis,corrected by 
zinc supplementation has indeed been observed in patients with zinc 
deficiency. 
Growth retardation, poor appetite, mental lethargy, skin changes and 
hypogonadism with delay in sexual maturation in the male were the 
typical clinical features of chronically zinc deficient subjects in 
the Middle East (Prasad in 1963). These features were corrected by 
zinc supplementation alone. 
Recently abnormal dark adaptation has also been related to a defi-
ciency of zinc( Morrison,l978). This effect is probably mediated by 
the enzyme retinol dehydrogenase which is present in the retina and 
known to be zinc dependent. 
In l974,Moynahan reported the features of profound zinc deficiency 
in patients with acrodermatitis enteropathica .This is an inherited 
disorder which can be treated by giving pharmacological doses of 
zinc. This disorder includes alopecia and vesicopustular lesions of 
the face, perineum and extremities.These are combined with parony-
chia ,esophagitis, diarrhea, a pronounced thymic atrophy and a high 
incidence of candida albicans infection .Left untreated this condi-
tion becomes fatal 
The role of zinc in testicular function was investigated in rats 
(Ley,l976) .These data indicated a specific effect on testes and 
suggested that testicular function in the zinc deficient state is 
affected through some alterations of testosterone biosynthesis in 
the male. 
A very high incidence of low birth weight and congenital malforma-
tions in children of patients with partially treated AE was reported 
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by Hambidge et al. (1975) .This suggests that zinc deficiency results 
in intrauterine growth retardation and congenital malformations in 
man as it does in animals.The results of zinc deficiency during 
pregnancy in the rat have indeed been described by Hurley and her 
colleagues 1973, 1976). Severe zinc deficiency resulted in total 
infertility. Less severe deficiency reduced conception by 50%, and 
the young animals weighed less than 50% of the control. Gross 
congenital malformations were present in 98%: cleft palate being the 
commonest followed by anophtalmia, anencephaly, hydrocephaly and 
fused or missing digits. According to Jameson (1976) zinc deficiency 
during pregnancy in the human female is characterised by increased 
maternal morbidity and increased risks (especially postmaturity)to 
the fetus. A possible correlation between a low maternal serum zinc 
level and congenital malformations mostly of the central nervous 
system has been postulated.The relation between maternal zinc defi-
ciency and the fetal alcohol syndrome needs further investigation. 
The human requirement for zinc seems to be higher than anticipated 
(Halsted,l974 Zlotkin, 1983). It has now become obvious that 
nutritional deficiency of zinc in the human is fairly prevalent 
throughout the world even in developed countries Sandstead,1973) 
and in well-nourished children Hambidge et al.( 1972; 1976 
identified ten children aged 4 to 13 years from middle and upper 
income class families.They had retarded growth and significantly de-
creased zinc levels in the hair .Old age, pregnancy and lactation 
have been associated with higher incidence of poor zinc status,as 
well as alcoholic liver cirrhosis and several other diseases asso-
ciated with poor nutrition ( Halsted,l970). Since the first observa-
tion of Kay and Tasman-Jones in 1975, numerous reports of a syndrome 
ressembling AE occurring in patients of all ages receiving zinc-free 
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TPN leave little doubt that zinc should be included in all TPN 
solutions ( ref.25 1 1979 ; Latimer,l980). 
compared to other metals as lead or arsenic, zinc is not very toxic. 
Pharmacological doses of zinc have been used without significant 
signs of toxicity.Oral ingestion of 12 gram of zinc sulfate taken 
over a two-day period caused slight drowsiness 1 lethargy and an 
increase in serum amylase and lipase levels( Murphy,l980). 
Inhalation of metal fumes has been known for many years to cause a 
clinical picture similar to an upper respiratory infection and at 
times pneumonia ( Papp, 1968). 
1.3 OUTLINE OF THE NUTRITIONAL ASPECTS £E TRACE ELEMENT METABOLISM 
DEFINITIONS 
Since growth and development require not only energy but also an 
adequate supply of all necessary nutrients,proper nutrition is of 
utmost importance during infancy and childhood .It is thus mandatory 
to provide essential trace elements according to the needs. 
The problem relies in estimating and specifying these needs.This is 
indeed of great practical importance for preventing ,detecting and 
deficiencies or abuses.Therefore it is necessary to treating 
blish the 
requirement 
esta-
requirement of an individual for a specific nutrient. The 
is a physiological concept .It may be defined as the 
minimal amount of that nutrient that will promote and maintain an 
optimal state of health (Fomon, 1974) .This is not an absolute value 
independent of other variables.Ideally the advisable intake of a 
nutrient should be identical to the reguirement.But estimates of 
requirements include a considerable element of uncertainty .There-
fore advisable intakes are set at values greater than the estimated 
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requirements.Although all recommendations must ultimately be based 
on data concerning requirements ,it should be noted that both recom-
mended dietary allowances(RDA) and recommended dietary intakes (RDI) 
are not identical with requirements. 
The U.S.National Academy of Sciences(Committee on Dietary Allowances 
of the Food and Nutrition Board of the National Research Council 
defines the recommended dietary allowances as: the levels of intake 
of essential nutrients considered,on the basis of available scienti-
fic knowledge,to be adequate to meet the known nutritional needs of 
practically all healthy persons (51). 
The U.K. Department of Health and Social Security defines the 
recommended dietary intakes for nutrients as the amounts sufficient 
or more than sufficient for the nutritional needs of practically all 
healthy persons in a population (77). Both RDA and RDI serve to 
evaluate and program the food supply of a population group. They are 
usually "high" enough to cover substantially all individual varia-
tions in the requirements of normal people .They include a margin of 
safety above the critical level of each nutrient.Therefore, the 
FAOfWHO introduced in 1973 the term safe level of intake: 11 the 
amount of protein considered necessary to meet the physiological 
needs and maintain the health of nearly all persons in a specified 
group" (59).This concept, defined here for protein, can be extrapo-
lated to other nutrients.Instead of the usual recommended dietary 
allowance ,"safe and adequate intakes11 are recommended for micronu-
trients that are clearly essential when a large degree of uncertain-
ty exists concerning the requirement (Rosenberg, 1985). This 
concept also has the advantage of introducing the idea of risks and 
therefore of probability.A person who has an intake lower than the 
safe level is not necessarily deficient but the lower the intake, 
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the greater the probability to become deficient. 
METHODS OF ESTIMATING REQUIREMENTS 
Different methods have been devised, especially in infants, to 
estimate the order of magnitude of the individual requirement. 
For a comprehensive review the reader is referred to Fomon (1974, 
1979), Committee on Nutrition (1979), Rosenberg (1985). 
The mineral content of human milk has been used preferentially for 
the calculation of trace element requirements for infants.Iron and 
zinc from human milk have been found to be uniquely and very effici-
ently absorbed by the infant. Consequently formulas and elemental 
diets had to be supplemented with higher amounts than expected in 
order to meet the requirement. 
Theoretically based calculations have also been used extensively to 
determine the requirement for infants .For example ,the requirement 
for zinc may be calculated from the estimated increase in fat-free 
tissue and on the assumed value for zinc concentration in this newly 
formed tissue (1,9 mg zinc/100 glean body mass in the newborn). 
Between birth and the age of 4 months an infant has to retain 320 ug 
of zinc daily to assure a normal increment in lean body mass. 
Many published allowances ,suggested by various investigators, are 
based on balance studies and clinical experience with administration 
of trace elements in TPN solutions .They are surprisingly close to 
each other and are actually extensively used in clinical settings. 
Reports of intakes by individuals~who developed symptoms of a defi-
ciency (indicating inadequate intakes) and reports of intakes by 
healthy individuals allow to calculate the dietary requirement with 
a large security margin. 
Aside from direct clinical experience ,many investigators have also 
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extrapolated data from human adults to infants or children and 
from the young or adult animals to human infants. 
Table.Safe and adequate levels of intakes of essential 
trace elements for infants (Tentative estimates ) o 
Zinc 
Copper 
Chromium 
Manganese 
Selenium 
oral ( mg /day) Intravenous (ug/Kg/day) 
3-5 ~ 
0.5 - 0.7 mg 
0.01- 0.04 mg 
o.5- 0.7 mg 
0.01- 0.04 mg 
100-500 ug 
20 ug 
0,1-0,2 ug 
2 - 5 ug 
o,s-2 ug 
°Fomon (1979), committee on Nutrition (1976), 
Ricour (1977), Zlotkin (1983),Hambidge (1983) 
FACTORS INFLUENCING REQUIREMENTS 
This Table reflects only provisional and tentative estimates of 
intakes .Many different factors are known to affect the requirement 
of a particular essential trace element : 
The composition of the diet may influence the requirement extensive-
ly. For example a high-energy diet without an adequate mineral 
intake enhances a deficiency state. 
Insufficient absorption may increase the requirement of the element. 
Because of the presence of phytate ,fiber and other complexing 
substances in soy and cereal protein , the requirement of zinc in a 
vegetarian diet may be higher than in a mixed type diet. Zinc may 
also be insufficiently assimilated in the presence of steatorrhea 
andjor diarrhea. 
Increased losses may occur either via the gastrointestinal tract or 
via other routes. It may be excreted via the urine in presence of 
proteinuria and aminoaciduria ,or through the skin with increased 
loss of sweat or following wounds and large surface burns.Alcoholism 
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induces also an important loss of zinc via the urine by an unknown 
mechanism. 
Trace elements should be given in a biologically active form avai-
lable for metabolic processes.For example,it is questionable whether 
the chromium present in intravenous solutions as contaminant is uti-
lised.The bioavailability may greatly be influenced by the presence 
of other elements in the diet : the absorption of copper is reduced 
in the presence of large zinc intakes as the availability of zinc is 
also reduced in the presence of iron. 
The requirement varies according to age and growth rate. The prema-
ture infants have smaller stores of energy and nutrients than the 
full term ones.They are physiologically less prepared to maintain 
homeostasis They have to gain a more rapid lean body mass in the 
first months of life in order to resume intra-uterine growth rate. 
Their intakes will consequently have to be adapted accordingly 
It is also to be remembered that the requirements of severely ill 
patients are higher than those of healthy individuals. 
l.4.PURPOSE Q!. TI!!§_ ~ 
To allow normal growth and development there are good reasons for 
giving iron,iodide,zinc,cobalt (as vitamine B 12 ),copper, and less 
known essential trace elem~ts such as selenium ,manganese,chromium, 
and possibly fluoride and molybdenum. 
The purpose of this study was to investigate and describe some 
aspects of the trace element metabolism in infancy and childhood. In 
chapter II, reference values of plasma selenium concentrations in 
Belgium and The Netherlands are given . The influence of age is 
discussed. Annotations on serum zinc and plasma copper are added for 
reason of completeness. There are no doubts that the nutritional 
intake which is geographically related ,exerts a profound influence 
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on the mineral status of a given individual. 
Therefore ,in chapter III we focused on the different aspects of 
the selenium intake of infants ,both in foods and in parenteral 
solutions. Reports of trace element deficiencies in patients recei-
ving parenteral nutrition andjor synthetic diets emphasized the need 
for more information on requirements. 
If the child is unable to absorb these elements in sufficient 
amounts they should either be supplemented with the foods, or 
provided parenterally. With this purpose , we studied in chapter IV 
the selenium ,copper and zinc status in 13 patients with cystic 
fibrosis. 
Four children with Wilson 1 s disease were investigated. The problems 
were multiple. The accumulation of copper in the liver and other 
tissues as the effects of the copper chelating therapy had both to 
be taken into consideration.In chapter V.l, the effect of D-Penicil-
lamine therapy is described .In Chapter V.2 the effect of zinc-
copper interaction during zinc sulfate therapy is discussed. 
In summary,examples of 4 different pathological mechanisms and their 
effect upon the metabolism of selenium ,copper and zinc will be 
presented :1) inadequate intake as seen in TPN 2) malabsorption 
represented by cystic fibrosis 3) increased urinary losses caused 
by the chelating agent D-Penicillamine 4) competitive inhibi-
tion of copper absorption through pharmacological doses of zinc 
sulfate. 
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CHAPTER II. REFERENCE VALUES 
2 .1 INFLUENCE OF AGE ON THE SELENIUM STATUS IN BELGIUM AND 
TF.E NETh"ERLANDS • 
M.VAN CAILLIE-BERTRAND (2l),H.J.DEGENHART (25) AND J.FERNANDES 
(22) • 
Department of Paediatrics, Erasmus University Rotterdam,University 
Hospital Rotterdam/ Sophia Childrens Hospital,Gordelweg 160, 3038 GE 
Rotterdam, The Netherlands. 
SUMMARY 
Plasma selenium concentration and glutathione peroxidase activity 
(GSH-Per) in red blood cells were determined in subjects from diffe-
rent age groups. The selenium level (mean ± SD) found in infancy 
(0 to 6 months) was 2 ± 0.6 ug/100 ml, with the lowest value of 1 
ugjlOO ml observed in a 4 months old infant. These levels were 
significantly lower (p<O.OOl) than the value of 9.5 ugjlOO ml ± 1.1 
found in the adult group and 7.7 ug/100 ml ± 1.3 found in the group 
of older children (2 to 15 years). Younger children (6 to 24 
months) had intermediate levels of 5 ug/100 ml ± 1.2. When the data 
were plotted on a logarithmic scale as a function of age the figure 
shows clearly that the plasma selenium levels increase steadily with 
age throughout life after an initial drop at 60 to 90 days. 
There was a satisfactory correlation between the plasma selenium 
concentrations and the GSH-Per activity in the red blood cells 
(r=0.45,p<O.OOS). Although very low selenium values were observed 
the GSH-Per activity remained (with only one exception) in all 
patients > 10 U/g Hb. 
Accepted for publication, Pediatric Research (July,1983) 
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INTRODUCTION 
Selenium is an essential nutrient for animals: it was recognized as 
such in l957 when Schwarz and Foltz showed in rats that its defici-
ency leads to necrotic degeneration of liver, pancreas, kidney and 
heart (12). It was not until 1979 ,however,that the existence of a 
human requirement for this element was described, when van Rij et 
al. observed a patient on total parenteral nutrition who developed 
tenderness in the thighs with inability to walk. This syndrome 
responded within a week to selenium supplementation given as sole 
therapy (17). Almost simultaneously an endemic cardiomyopathy, 
occurring mainly in infants and children and known in China as 
Keshan disease, was reported to be prevented with supplementation of 
selenium (2), confirming the growing evidence t.~at selenium might be 
essential for the function of the heart and other muscles in man. 
Although selenium is found in a muscle protein (12), its only well 
characterized and essential biochemical function in mammals is in 
the enzyme glutathione peroxidase (GSB-Per, EC 1.11.1.9), which is 
known to be subjected to cyclic redox changes during its catalytic 
action (3). This enzyme is thought to have a major function in the 
removal of H 0 and organic peroxides generated during oxidative 
2 2 
metabolism in cells and tissues, providing an efficient means of 
defense against the build-up of such peroxides which otherwise are 
able to damage cell membranes and macromolecules including DNA (13). 
It also interacts at 2 sites of the arachidonic acid cascade, 
preventing the accumulation of prostaglandin G (which might be 
essential for t.~e inflammatory responses of tissues) and regulating 
prostacyclin biosynthesis which ir~ibits the aggregation and adhe-
sion of platelets to the endothelial lining of blood vessels (1). 
Selenium levels in adult man have been shown to correlate with the 
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selenium content of soils and foods (15). The determination of the 
selenium requirement is therefore of particular importance in those 
countries where the selenium intake is on the borderline, as is the 
case in Belgium and The Netherlands (18). Few data are presented in 
the literature on the selenium status of infants, children, adults 
and elderly in Western-Europe. To obtain this information plasma 
selenium levels and activity of GSH-Per in red blood cells were 
determined as possible functional parameters of adequate selenium 
status in subjects from different age groups. 
MATERIALS AND METHODS 
Blood samples were obtained from 25 infants (0-24 months), all 
R 
receiving the same humanized cow's milk infant formula (Almiron 
Nutricia and from 16 children (2-15 years) who had to undergo 
either minor operations of diagnostic procedures or were seen at 
the outpatient department at a last follow up visit after an acute 
illness. All were growing well and had a height and weight > P3 for 
age. Ten adults were members of the laboratory staff, 5 were healthy 
relatives and 5 were seen at the Department of Medicine for minor 
complaints. 
All samples were collected and stored in metal free tubes. After 
centrifugation at 2800 rpm, plasma and red blood cells were sepa-
rated and kept frozen at -70° until analysis. The glutathione 
peroxidase activity of the red cells was measured at 30° in a zeiss 
PMQ III spectrophotometer, using the coupled test procedure with the 
substrate t-butylhydroperoxide as described by Paglia and Valentine 
(8) and was expressed as units per gram hemoglobin One unit was 
defined as the amount of enzyme that would catalyse the oxidation of 
1 nM.NADPH/min. under the conditions of the assay. Storage of frozen 
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samples at -70° was shown to have no effect on enzyme activity. 
Reduced glutathione, GSSH reductase and NADPH were obtained from 
Boehringer Mannheim. 
The plasma selenium concentrations were determined by the fluoro-
metric method of Watkinson (19). 2.3-Diamino-naphtalene (Fluka) was 
used as complexing reagent and cyclohexane (Baker) as the extracting 
solvent for the complex. The fluorescence was measured in a Baird 
Atomic fluorometer, model SF-1. Excitation wave length = 366 nm, 
fluorescence wave length = 516 nm. The selenium content was expres-
sed as ug/100 ml. 
RESULTS 
Figure l reports the plasma levels of selenium from all 61 subjects 
as a function of age on a logarithmic scale. The solid line is a 
computer-drawn cubic spline fitted on the data points. As can be 
seen from the figure, the mean (± SD) plasma selenium concentrations 
found in the very young infant group ( 0 to 6 months) reaches the low 
values of 2 + 0.6 ug/100 ml (rar.ge: 1 -3.2 ugjlOO ml), the 5 infants 
younger than 60 days sho·wing a level slightly higher (2. 2 + 0. 5 
ug/100 m1) than those 60 days and older (1.8 ± 0.8 ug/100 ml). The 
lowest value (1 ug/100 ml) wa.s found in a 4 months old infant. 
These levels were significantly lower (p <0.001) than the value of 
9.5 + 1.1 ug/100 ml found in the adults (range: 7.2 - 11.6 ug/100 
ml) or the value of 7.7 + 1.3 ug/100 ml found in the older children 
(range: 5.3 ug/100 m1 - 10.4 ug/100 m1). 
Younger children (6 to 24 months) had intermediate levels with a 
mean (± SD) of 5 ± 1.2 ug/100 m1 (range: 2.8 ug/100 m1- 7.3 ug/100 
ml). The figure shows also that the plasma selenium value increases 
steadily with age throughout life, after an initial drop at about 4 
months of age. 
28 
Figure 2 shows the correlation between the plasma selenium concen-
tration and the RBC glutathione peroxidase activities in 44 subjects 
(r=0.45; p < 0.005). Although very low selenium values were obser-
ved, particularly in the very young infants, the glutathione peroxi-
dase activity remained at all time but once above 10 U/g Hb. Most 
remarkably the mean activity found in the group of young infar.ts 
(18.2 ± 6.8 U/g Hb) did not differ significantly from the value 
found in the 6 to 24 months old group (l8.l + 6.8 U/g Hb) nor from 
the value found in the group of older children (22 .s + 7 U/g Hb). 
Adults reached the highest levels of activities ( 27 ± 8 U/g Hb); 
range: 10.5- 40 U/g Hb), although those, taken as a group, were not 
statistically significantly different from the levels found in 
infancy. 
DISCUSSION 
Only a few studies on the selenium status of growing children have 
been published (5,7,20). The plasma selenium concentrations we 
report here in infants fed humanized cow's milk formula and in 
children and adolescents with an adequate nutritional status as 
assessed by growth parameters agree well with the findings of Lom-
beck in Germany (5). It confirms the fact that selenium in man as 
well in the animal (9) is age dependent, which would support the 
existence of a maturation process. It also extends this information 
to the Benelux countries (Belgium - The Netherlands - Luxemburg) of 
Western-Europe. 
The lowest values were observed in infants 60 to 90 days old, and 
reached levels (1 ug/100 ml) comparable to those reported in adults 
with clinical selenium deficiency (17). The plasma selenium levels 
of healthy adults from The Netherlands are comparable to the values 
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found in Germany (5) and in Finland (20). They are at least 2 to 3 
times lower than the levels observed in the residents of the United 
states, Canada or Japan where values up to 17-22 ug/100 ml are found 
(12). According to Valentine a deficient status is improbable with 
plasma selenium concentrations above 10 ug/100 ml (16). As can be 
seen from the figure the levels reported here in the adults are 
borderline and those observed in infants and children dramatically 
low. 
Selenium levels have been reported to correlate well with the sele-
nium content of the diet (15). Calculated daily intakes are low in 
The Netherlands but also in all the North of Western-Europe inclu-
ding Sweden, Finland and West-Germany (18). The extremely low 
levels seen in infancy (circa 10% of adults values) are most probab-
ly due to the low selenium content of cow's milk as compared to 
human milk (6), but could also be due to the insufficient availabi-
lity andjor storage of selenium during pregnancy, the cord levels 
being a function of mother's selenium status (10). This latter, as 
seen on the figure, is on the borderline and sometimes even inade-
quate in the countries where the daily intake of selenium is low. 
As others (3,5,7,13), we found a positive relationship between 
plasma selenium levels and the GSH-Per activity in the red blood 
cells. The fact that this relationship exists suggests that the 
selenium requirement is not met: indeed t.~e enzyme activity, in 
adults, depends strongly on the selenium supply until a plateau of 
activity is reached (3). There is now accumulating evidence that 
the activity of GSH-Per is submaximal at selenium concentrations of 
less than 10 ug/100 ml. Notewort_~y in this respect are the GSH-Per 
activities found in the group of young infants. The activities are 
lower but not significantly different from those seen in older 
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children and adults, despite the very low selenium values. The 
question has to be raised whether this represents a residual activi-
ty reflecting Se status at the moment of red blood cell formation or 
the activity of a non-selenium dependent GSH-Per in this age group. 
The existence in Western Europe of a causal relationship between low 
selenium levels and a clinical disorder has not yet been convincing-
ly demonstrated. Nevertheless a subacute deficiency existing for 
some time might induce a metabolic or histopathological change which 
on its turn could trigger a disease at some future time when the 
deficiency itself may not be detectable anymore (3) . In this pros-
pect, ~~e recently reported study describing the correlation between 
a subacute selenium deficiency and myocardial infarction and cardio-
vascular diseases is particularly important (11). Further epidemio-
logic studies are urgently needed. A more practical and direct way 
to detect and quantify lipid peroxidation and the influence of the 
selenium status on this process is probably the measurement of 
alkanes like ethane and pentane (4). 
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Selenium concentrations in plasma of 61 individuals of different 
ages. 
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Plasma selenium concentrations and glutathione peroxidase activities 
in red blood cells of 44 individuals of different ages. 
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~ ANNOTATIONS ON PLASMA COPPER ~ ~ ZINC CONCENTRATIONS 
PLASMA COPPER CONCENTRATION 
Copper is an essential trace metal,involved in cell and tissue 
growth.Dietary deficiency of copper is extremely rare.It is seen 
almost exclusively in very low birth weight premature infants 
(l),and in term infants on total parenteral alimentation without 
copper supplementation (2).Menkes kinky hair syndrome has been reco-
gnised by Danks et al.in 1972 as a congenital and inherited disease 
of copper metabolism ( 3 ) . Most problems are due to accumulation 
of copper into the tissues (4,5). 
We assessed in our laboratory the plasma copper values in a group of 
14 children older than 2 years , who had to undergo either minor 
operations or diagnostic procedures or were seen at the outpatient 
department at a last follow-up visit after an acute illness. 
All samples were collected and stored in metal free containers 
After centrifugation at 2800 rpm ,the plasma was kept at -7oo,until 
analysis.The copper content was estimated in duplicate by atomic 
absorption spectrophotometry ,using a graphite tube ( Perkin - Elmer 
303 .We compared the data obtained with the scarce but classic 
pediatric reference values reported in the literature ,which are 
summarized in the Table. 
The results obtained (120 + 22 ugjlOO ml, range: 92 - 151 ug/100 
ml) are comparable to those previously described . 
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Plasma copper concentrations ( 6, 7 ). 
Age Number Mean Values SD Range 
(ug /100 ml) (ug/100 ml) (ug/100 ml) 
Birth 15 29 3 
20 to 70 
2 to 6 8 64 5 
months 
6 month to 
5 years 27- 153 
5 to 17 years 94- 230 
Adults 82 106 18 70- 118 
Conversion factor ug/100 ml to umol/1 : 0.157. 
As shown by Henkin 6) and Scheinberg et al.( S ),the mean 
concentration of total plasma copper at birth was significantly 
lower than the adult level .It showed a consistent rise during the 
first months of life, until the age of s months .At this age it 
remained relatively stable for the next 13 months at values signifi-
cantly above the adult levels ( 6 ) . 
Mean nondiffusible copper and ceruloplasmin levels in the newborn 
infant are about a fourth of the adult values. They show a subse-
quent gradual increase , which closely parallel the change obser-
ved in total plasma copper concentration. In the later period of 
infancy,and up to 6 years of age the copper level is higher than in 
the adult .From the age of 6 years till the age of 13 to 16 years, 
the total plasma copper concentration decreases gradually to the 
adult value 
These data showed a specific profile of plasma copper concentration 
during infancy,different from that of plasma zinc.It is therefore 
remarkable that while serum levels of copper and ceruloplasmin are 
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the lowest at birth, the copper content of fetal and neonatal tis-
sues, particularly liver, muscle, skin, adrenal glands,thyroid, 
testes,and uterus is much higher than in adults ( 9 ) . These tissue 
levels decrease soon after birth while there is a corresponding rise 
in plasma copper and ceruloplasmin concentrations (10) . 
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ZINC 
Zinc has been known to be an essential trace metal for mammals since 
1934 1 and for man since 1963 (2 ) .The hypothesis that the 
nutritional zinc intake in the western world might at times be 
marginal, could have been seen as ridiculous until several years 
ago. Deficiencies were first documented in 1973 (4) and later con-
firmed by Walravens and Hambidge in a group children from low - and 
middle class American families in Denver (5). 
Quite rapidly since those first reports it became clear that human 
zinc deficiency may occur under certain circumstances, even in the 
presence of an adequate energy and protein intake. 
A severe acute zinc deficiency has been described in patients with 
acrodermatitis enteropathica (6 )and in patients treated with long-
term parenteral alimentation without zinc supplementation (7). 
Marginal, mainly secondary zinc deficiency has since been observed 
in patients with the syndrome of protracted diarrhea in infancy (8), 
with coeliac disease (9) ,in very low birth weight infants fed 
parenterally (10), in adults with cirrhosis (11), with crohn •s 
disease (12 ) and in a continuously growing number of other patholo-
gical entities (13). 
we assessed in our laboratory the values of serum zinc concentra-
tions in healthy individuals of different ages Serum samples were 
obtained from 21 infants (age: 0 to 24 months), 
all receiving the same humanised cow's milk formula 
R 
(Almiron 
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Nutricia ) and from 18 children (2 to 15 years) who had to undergo 
either minor operations or diagnostic procedures or were seen at the 
outpatient department at a last follow-up visit after an acute 
illness.All were growing well and had a height and weight > p 3 for 
age.The samples were drawn between 8 and 12 a.m. 
In 11 healthy adults the zinc levels were determined ,and in 7 this 
was done in fasting and non fasting condition. 
All samples were collected and stored in metal free containers 
After centrifugation at 2800 rpm ,the serum was kept at -7oo,until 
analysis.The zinc content was estimated in duplicate by atomic 
absorption spectrophotometry, flame detection, Perkin- Elmer 303. 
We compared the data obtained (Table below) with the pediatric 
reference values reported in the literature. 
Serum zinc concentrations. 
Age Number Mean Values SD 
( ug /100 ml) (ug/100 ml) 
2 to 5 9 92 23 
months 
6 to 24 12 103 14 
months 
2 to 18 18 101 10 
years 
Adults 11 117 20 
Fasting 7 116 20 
Non-fasting 7 118 28 
Range 
(ug/100 ml) 
61 - 136 
85 
- 124 
90 -120 
87 -150 
97 -150 
87 -140 
-------------------------------------------------------------------
* Conversion factor ugjlOO ml to umoljl: 0.153 
Detailed studies on zinc concentrations in infancy and childhood 
have been published by Henkin et al. (14) and by Kasperek et al.(l5) 
who used capillary blood collected at various times of the day.They 
determined the zinc content by neutron activation. Both authors 
reported a slightly increasing trend in zinc values in infancy. This 
was almost simultaneously confirmed by the Denver group (16). 
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Kasperek reported a serum zinc value of 82 ~ 15 ug/100 ml for 
infants less than l year,97 ~ 20 ug/100 ml for children from 1 to 5 
years,100 ~ 16 ug/ 100 ml for children from 5 to 12 years and 117 + 
17 ugj 100 ml for adults.The values found in our own laboratory for 
serum zinc concentrations in children as well as in adults are 
compatible with these literature data ( 14, 15, 16, 17 ) • 
Minor changes of the serum zinc levels after feeding have been 
described This is particularly true if one compares each indivi-
dual's levels in a fasting and non fasting state.Taken as a group 
however ,these variations remain within the limits of the reference 
range. They do not reach pathological values as described in clear 
cut deficiency syndromes (- 25 % of the lower limit ) . 
Variations of zinc values according to circadian rythm and stress 
were described several years ago (18). In a marginal state of zinc 
deficiency, one single assay is usually insufficient to establish 
the diagnosis with certainty .A combination of different data will 
be required .Provided the sample is not hemolysed or contaminated, 
the plasma zinc level remains a very useful parameter for the 
assessment of the zinc status (13). 
serum zinc levels are reported to be approximately 16 % higher than 
those found in plasma .This was extensively investigated by Foley et 
al. (19,20} who attributed the effect to the aggregation of the 
platelets with subsequent release of zinc during clotting. These 
data were not confirmed by other investigators (17,22). 
Sources of contamination should systematically been sought for and 
eliminated. To cite just a few: the rubber stoppers of vacutainer 
tubes (21,22),1eaching their zinc content into the sample to be 
R R 
tested ,and all the zinc containing creams as Inotyol and calamine. 
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CHAPTER~ NUTRITIONAL ASPECTS. 
3.1 LONGITUDINAL STUDY OF THE SELENIUM CONTENT IN HUMAN BREAST~ 
IN BELGIUM 
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ABSTRACT 
The selenium content of expressed human milk obtained at different 
stages of lactation from 32 lactating mothers was measured by 
hydride generation atomic absorption spectrometry after previous wet 
acid digestion. The highest selenium level was found in colostrum 
(14.8 ngjg; wet weight) subsequently the content declined and 
levelled off after one month (9.4 ngjg; wet weight). 
The daily selenium intake for Belgian infants of 3 months of age was 
found to be 7.1 ug (girls) and 8.1 ug (boys), which is lower than 
the values obtained in most other countries and lower than the 
recommended safe and adequate daily intake of 10 to 40 ugjday for 
the same age group. 
Key words: Selenium, breast milk, infant intake. 
Accepted for publication in Acta Paediatr. Scand.( March 1984 ). 
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There has been an ever increasing interest in the role of selenium 
in human nutrition (l) .Low selenium intakes have been associated 
with Keshan disease, a juvenile cardiomyopathy that occurs in cer-
tain parts of China (2,3); and various signs of selenium-responsive 
symptoms have been reported in patiens undergoing long term feeding 
with intravenous solutions that are pratically devoid of selenium 
(4-6). Moreover, epidemiological studies have suggested that low 
selenium intakes may be related to an increased incidence of cancer 
(7,8) and cardiovascular disease (9). 
Breast milk is the only source of selenium for breast-fed infants. 
Although some reports on selenium content of breast milk are availa-
ble in the literature (10-20) ,longitudinal studies of selenium con-
tent of breast milk are scarce (21-25) and no data for the Belgian 
population are available hitherto. 
The purposes of this study are (1) to estimate the selenium content 
of breast milk obtained from Belgian lactating women at different 
periods of lactation, (2) to compare the obtained data with litera-
ture values and (3) to estimate the daily intake of these breast-fed 
infants. 
MATERIALS AND METHODS 
Sampling 
Thirty-two healthy Belgian women, aged between 17 and 37 years, 
donated milk samples, obtained by expression, during the first six 
months of 1983. All subjects had delivered healthy, fullterm 
infants and did not experience any complications during pregnancy or 
at delivery. They had been living for at least one year in the 
surroundings of Antwerp and they were sampled at different times. 
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Colostrum milk was taken during the first three days, 
tional milk was sampled 5 up to 10 days post partum. 
was sampled after 1 and 2 months of lactation. 
while transi-
Mature milk 
From 14 mothers three or four samples were available, while the 
others provided only one or two samples. Sampling occurred in the 
morning before 
was obtained 
tubes. 
ANALYSIS 
the infants were due to be fed.Approximately 10 ml 
in acid-rinsed glassware and store i~ polyethylene 
For the selenium determination a hydride generation atomic absorp-
tion spectrometry with a Perkin-Elmer 372-MHS-1-unit, a high-purity 
quartz tube, closed at both ends by quartz windows, was used for 
atomization. Conditions for the evolution of hydrogen selenide have 
been described elsewhere (26). A nitric-perchloric acid digestion 
was previously carried out on about 10 ml samples, according to a 
procedure recommended by Robberecht and co-workers (27) . 
Throughout the method of standard addition was used for the calcula-
tion of concentrations. 
RESULTS AND DISCUSSION 
The selenium content of 73 milk-samples, taken at different stages 
of lactation, including one sample of pooled breast milk, are summa-
rized in table 1. 
As can be seen the selenium content of expressed human breast (fore-
milk) from Belgian mothers decreased with increasing time of lacta-
tion and levelled off on a concentration level of about 9.4 ngjg. 
No comparison with hindmilk can be made since only foremilk was 
sampled. 
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Distribution patterns revealed that 72% of the colostrum milk had a 
concentration level between 10 and 19.9 ngjg; 75% of the transitio-
nal milk had a selenium content varying between 5 and 14.9 ng/g, 
whereas 65% of the mature milk showed a concentration between 5.0 
and 9.9 ngjg.Two milk samples,obtained after 2 months of lactation 
revealed distinctly higher concentrations, 14.4 and 15.4 ng/g 
respectively. 
Individual longitudinal studies of the selenium content of human 
breast milk revealed that not all subjects showed the general pat-
tern of decreasing selenium content. Probably food consumption 
habits or other factors regulate the milk selenium content. Shearer 
and Hadjimarkos (17) claimed that the selenium concentration in 
human milk reflected a different selenium intake via 
Levander and coworkers (18) were unable to find 
food, whereas 
between the selenium content in the breast milk 
any 
and 
correlation 
the dietary 
selenium intake by the mother. For Finland Kumpulainen and cowor-
kers (25) proved that imported grain from the USA with high selenium 
content may be responsible for the different curves obtained in a 
longitudinal study of human breast milk samples. 
Literature data on changes in selenium content of human breast milk 
samples during the lactation period are summarized in table 2, while 
table 3 contains additional data on selenium content of other breast 
milk samples. Specification of the samples is included in the 
table, as far as it is mentioned in the references. 
All concentrations were converted to ngjml by using a density of 
1.034 (28) or a mean dry to wet ratio of 0.12 (15,21,28). All the 
data in table 2 show a significant decrease of the selenium content 
of t.~e milk with increasing time of lactation and a levelling off 
at one month. 
48 
ACKNOWLEDGEMENTS 
The authors wish to thank the Belgian Ministry of Health (Division 
of Food Inspection) for their financial support. Hilde Lambrechts 
carried out the selenium determinations, while Dr. P. Vandenberghe 
provided the breast milk samples. 
49 
REFERENCES 
1. Levander OA. Clinical consequences of low selenium intake and its 
relationship to vitamin E. Ann NY Acad Sci 1982; 393 : 70-82. 
2. Keshan Disease Research Group. Observations on effect of sodium 
selenite in prevention of Keshan disease.Chin Med J 1979;92:471-476. 
3. Keshan Disease Research Group. Epidemiologic studies on the 
etiologic relationship of selenium and Keshan disease. Chin Med J 
l979; 92: 477-482. 
4. Van Ry ~~~Thomson CD,McKenzie JM,Robinson MF. Selenium deficiency 
in total parenteral nutrition.Amer J Clin Nutr 1979; 32: 2076-2085. 
s. Johnson RA, Baker ss, Fallon JT, Maynard ED, Ruskin JN, Wen z, Ge 
K, Cohen HJ. An occidental case of cardiomyopathy and selenium 
deficiency. N Engl J Med 1981; 304: 1210-1212. 
6. Kien CL, Ganther HE.Manifestations of chronic selenium deficiency 
in a child receiving total parenteral nutrition.Amer J Clin Nutr 
l983; 37: 3l9-328 
7. Committee on Diet, Nutrition and Cancer. Diet, nutrition and 
cancer. Washington, DC, 1982, National Academy of Sciences. 
8. Willett WC, Morris JS, Pressel S, Taylor JO, Polk BF, Stampfer 
HJ, Rosner B, Schneider K, Hames CG. Prediagnostic serum selenium 
and risk of cancer. Lancet 1983; ii : 130-134. 
9. Salonen JT, Alfthan G, Huttunen JK, Pikkarainen J, Puska ?. 
Association between cardiovascular death and myocardial infarction 
and serum selenium in a matched-pair longitudinal study. Lancet 
l982; ii : l75-l79. 
10. Miller KR, Sheppard AD. Tocopherol and selenium levels in human 
and cow 1 s milk. N Z J Sci 1972; 15: 3-15. 
11. CUmming FJ, Fardy JJ, Briggs MH. Trace elements in human milk. 
Obstet Gynecol 1983; 62: 506-508. 
50 
12. Hadjimarkos DM, Shearer TR. Selenium in mature human milk. 
Amer J Clin Nutr 1973; 26 :583. 
13. Clementi GF,Ingrao G,Santaroni G.The concentration of some trace 
elements in human milk from Italy. Sci Total Env 1982; 24: 255-265. 
14. Hojo Y. Selenium concentration and glutathione peroxidase acti-
vity in cow's milk. Biol Trace Elem Res 1982; 4 : 233-239. 
15. Cross JD, Raie RM, Smith H, Smith LB. Dietary selenium in the 
Glasgow area. Radiochem. Radioanal. Letters 1978; 35: 281-290. 
16. Farre R, Gonzalez M, Marsa M. Morros R. Selenium content in 
commercial baby milk powders and paps. Rev Agroquim Tecnol Aliment 
1981; 21: 554-560. 
17. Shearer TR, Hadjimarkos DM. Geographic distribution of selenium 
in human milk. Arch Environ Health 1975; 30: 230-233. 
18. Levander OA, Morris VC, Moser PB. Dietary selenium (Se) intake 
and Se content of breast milk and plasma of lactating and non-
lactating women. Fed Proc 1981; 40 : 490. 
19. Amin s, Chen Y, Collipp P, castro-Magana M, Maddaiah v, Klein s. 
Selenium in premature infants. Nutr Metab 1980; 24 : 331-340. 
20. Kosta L, Byrne AR, Dermelj M. Trace elements in some human milk 
samples by radiochemical neutron activation analysis. Sci Total Env 
1983; 29: 261-268. 
21. Lombeck I, Kasperek K, Bonnerman B, Feinendegen LE, Bremer HJ. 
Selenium content of human milk, cow's milk and cow's milk infant 
formulas. Eur J Pediatr 1978; 129 : 139-145. 
22. Grimanis 
C.Determination 
AP, Vassilaki-Grimani M, Alexiou D, Papadatos 
of 7 trace elements in human milk, powdered cow's 
milk and infant foods by neutron activation analysis. Proc. Nuclear 
Activation Techniques in the Life Sciences, IAEA, Vienna 1978; 241. 
23. Smith AM, Picciano MF, Milner JA. Selenium intakes and status of 
;1 
human milk and formula fed infants.Amer J Clin Nutr 1982;35:521-526. 
24. Higashi A,Tamari H,Kuroki Y,Matsuda !.Longitudinal changes in 
selenium content of breast milk.Acta Paediatr Scand 1983;72:433-436. 
25.Xumpulainen J, vuori E, Siimes M. Effect of dietary selenium 
intake on selenium levels in breast milk. Proceedings "Health 
Effects and Interactions of Essential and Toxic Elements", Lund, 
Sweden, June 13-18, 1983 • 
26. Verlinden M, Baart J. Deelstra H. Optimization of the determi-
nation of selenium by atomic absorption spectrometry: comparison of 
two hydride generation systems. Talanta 1980; 27: 633-639. 
27. Robberecht HJ, Van Grieken RE, Van Den Bosch PA, Deelstra HA, 
Vanden Berghe DA. Losses of metabolically incorporated selenium in 
common digestion procedures for biological material. Talanta 1982; 
29 : 1025-1028. 
28.Iyengar GV. Elemental composition of human and animal milk: a 
review. International Atomic Energy Agency, 
Vienna, 1982, IAEA-Tecdoc 269. 
29. Robberecht EJ, Deelstra HA. Dietary selenium intake in Belgium. 
Z Lebensm Unters Forsch, 1984; 178 : 266-271. 
30. Griffiths NM. Dietary intake and urinary excretion of selenium 
in some New Zealand women. Proc Univ otaga Med Sch 1983; 51: 8-9. 
31. Schelenz R. Dietary intake of 25 elements in man estimated by 
neutron activation analysis. J Radio Anal Chem 1977; 37: 539-548. 
32. Schrauzer GN, White DA. Selenium in human nutrition: dietary 
intakes and effects of supplementation.Bioinorg Chem 1978;8:303-318. 
33. Yasumoto K, Iwami K, Yoshida M, Mitsuda H. Selenium content of 
foods and its average daily intake in Japan. J Jap Soc Food 
Nutr 1976; 29 : 511-515. 
34. Food and Nutrition Board (National Research Council-USA) Recom-
52 
mended dietary allowances. Nutr Rev l980; 38: 290-294. 
35. Whitehead RG, Alison AP, Cole TJ. How much breast milk do 
babies need? Acta Paediatr scand 1982; suppl 299: 43-50. 
Address: Harry Robberecht, Provinciaal Hoger Technisch Instituut voor 
Scheikunde; Kronenburgstraat 47, B-2000 Antwerp, Belgium. 
53 
Table 1. Selenium content (nq/g; wet weight) of human breast milk in 
Belgium. 
Type of milk Lactation time n Selenium concentration 
(days post partum) 
mean :t SD median range 
Colostrum 0 - 3 24 14.8 + 4.9 15.0 6.6-27.2 
Transitional 5 - 7 13 12.3 :!: 4.4 11.0 5.5-18.7 
8 - 10 11 12.7 :!: 3.5 12.6 6.7-17.7 
Mature 30 15 9.4 + 2.0 8.9 6.7-12.7 
60 9 9.9 :!: 3.4 9.0 5.6-15.4 
Pooled human 1 9.3 
milk 
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Table 2. Longitudinal changes of the selenium content (nq/ml) of human breast milk. 
Sampling location n 
(year) 
New Zealand 
(1972) 
West Germany 
(1978) 
Greece 
(1978) 
USA 
(1982) 
Japan 
(1983) 
Belgium 
(1983) 
* median value 
6 
3 
15 
18 
7 
24 
Colostrum 
(0-3 days) 
26 + 10 
(12=35) 
84 
(65-108) 
48 
(33-69) 
41. 2+17. 3 
80* 
(35-152) 
15.3 + 5 
(7-27) 
n 
16 
25 
15 
10 
24 
Transitional milk 
(4-10 days) 
13 + 4 
30.5 
(16-53) 
16 
(10-20) 
29* 
(15-79) 
12.7 + 4.5 
(6-19) 
n Mature 
milk 
Specification ref 
10 
44 28,3 11-173 days 21 
(11-54) 
5 15 1 month 22 
(11-22) 
8 18,0+3,8 
8 15.7+4.6 
8 15.1+5.8 
9 18* 
(9-39) 
8 17* 
(6-28) 
7 18* 
(9-33) 
15 9,7+2.1 
9 10.2+3.2 
1 9.6-
1 month 
2 months 
3 months 
1 month 
3 months 
5 months 
23 
23 
23 
24 
24 
24 
1 month this 
2 months study 
pooled mature 
milk 
"' 
"' 
Table 3 Literature data on the selenium content (ng/ml) of human breast milk. 
Sampling 
Location n 
Australia 40 
Greece (Athens) 24 
Italy 130 
Japan 13 
Scotland (Glasgow) 25 
spain (Barcelona) 8 
USA (17 states) 241 
(Beltsville) 
(New York) 
Yugoslavia 27 
(Ljubljana) 
Concentration level 
mean ± SD range 
12 + 2 
21 + 1 
13.8+ 0.9 1 - 51 
22.5 + 4.2 
31 + 10 
ll. 4 + 3 9 - 18 
19 + 0. 4 7 - 62 
20 + 4 
15 + 3.5 
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3l 
11.5 .±. 3.6 5,7 - 16,7 
Specification Ref. 
mature milk 11 
29-195 days post partum 12 
21 mothers,l5 days post 
par tum 
mature milk 
3-10 days post partum 
17-869 days post partum 
1 month post partum 
3-6 months post partum 
colostrum 
0-14 days post partum 
13 
14 
15 
16 
17 
18 
18 
19 
19 
20 
Table 4. Estimated daily intake £f selenium (ug(day) for infants 
country 
Belgium 
Germany (West) 
Japan 
New Zealand 
Spain 
u.s.A. 
Average Se 
intake 
8.1 
7.1 
22 
8 
17 
5 
2 
4,5 
7 
10 
Specification ref 
breast milk, third month 
840 mljday (boys) this study 
740 mljday (girls) this study 
breast milk, 2 month 21 
cow's milk, infant formula 
second month 21 
breast milk, first 5 months 24 
breast milk, first month 10 
bottle-fed cow's milk 
first month 10 
breast milk, 5-6 months 16 
bottle fed cow's milk, 
S-6 months 16 
breast milk, third month 
683 mljday 23 
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~ DAILY INTAKE 2f SELENIUM OF BOTTLE FED INFANTS IN BELGIUM. 
(l) 
E.ROEKENS , H. 
(2) 
AND R. CLARA. 
(l) (2) 
ROBBERECHT , M. VAN CAILLIE-BERT~~D , 
l 
(l) 
H. DEELSTRA 
From the Department of Pharmaceutical Sciences,University of Antwerp 
2 
and t.~e Antwerp Children's Hospital , University of Antwerp, Belgium. 
ABSTRACT 
The selenium content of commercial infant formula, processed milk 
and beikost was measured by hydride generation atomic absorption 
spectrometry after previous wet acid digestion. The median daily 
intake of infants (l-6 months) fed milk, soja or cereal based infant 
formula was 3.0-7.8 ugjday; this is lower than the mean daily intake 
of Belgian breast-fed infants (6.1-8.6 ugjday) and cow's milk 
bottle-fed infants (7.6-10.8 ugjday). 
Key words: selenium, infant formula, cow's milk, daily intake. 
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INTRODUCTION 
Interest in the role of selenium in human nutrition is increasing as 
more and more investigators realize the essentiality of this trace 
element for human health (5,8,18). 
The clinical features of human selenium deficiency are not yet 
characterized. There have been reports on low plasma selenium 
levels in patients receiving total parenteral nutrition for a long 
time (4) and in children living on artificial diets, providing only 
l.0-4.7 ug Sejday (9,12,13). Low serum concentrations have been 
reported for premature infants with severe respiratory distress. 
After feeding a regular diet with a high selenium concentration 
serum concentrations returned to normal levels (1). 
The Food and Nutrition Board (USA) has proposed adequate 
intakes of selenium for infants (0-l year): 10-60 ugjday; 
but safe 
children 
(1-6 year): 20-120 ugjday; children (older than 6 years) and adults: 
so-200 ugjday (9). 
Daily intake by Belgian breast-fed infants has been determined by 
analysing the selenium content of human breast milk in Belgium (16). 
Since breast feeding is often replaced by artificial food, based on 
cow's milk or infant formula, the purposes of this study are (1) to 
clarify the selenium content of infant formula, cow's milk and 
beikost (2) to estimate the daily intake of artificially fed infants 
and (3) to compare the obtained data with literature values. 
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MATERIALS AND METHODS 
1. Sampling 
Twenty-five samples of commercial infant formula were obtained from 
the Antwerp Children's Hospital. 
Eleven samples of processed cow 1 s milk, sixteen samples of milk pro-
ducts, nine samples of strained baby food and five samples of cereal 
infant formula were purchased from local stores. 
Ten samples of freshly prepared fruit porridge were obtained from 
different children gardens in Brussels. 
Perishable samples were stored in a deep-freezer at -20 C, prior to 
analysis. 
2. Analytical method 
Hydride generation atomic absorption spectroscopy with a Perkin-
Elmer 372-MHS-1-unit and a high-purity quartz tube, closed at both 
ends by quartz windows, for atomization was used for the selenium 
determination. Conditions for the evolution of hydrogen selenide 
have been described elsewhere (21). A nitric-perchloric acid diges-
tion was previously carried out on about 10 ml or 1 g samples, 
according a procedure recommended by Robberecht and coworkers (15). 
The method of standard addition was used for concentration calcula-
tion through-out. 
Triplicate analysis of the milk powder reference material IAEA-A 
gave a mean selenium concentration of 31.8 ± 2.5 ngjg.The concentra-
tion, recommended by the IAEA with an "acceptable11 degree of confi-
dence is 33.9 ± 7.2 ngjg. Triplicate analysis of the milk powder 
reference material NBS 1549 gave a mean selenium concentration of 
106 ± 5 ngjg. The concentration, recommended by NBS is 110 ± 10 
ngjg. 
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RESULTS 
The results of the analysis of different infant formula are summa-
rized in table 1. The formula are classified according to Roelandts 
(17) • Three major classes are distinguished: milk based formula, 
soya based formula and milk formula for therapeutic use. 
The milk based formula are subdivided in three classes: humanised 
milk for prematures and very young infants, soft milk, with a compo-
sition that approaches the composition of cow's milk and acidified 
milk, easier to digest through acidification of the proteins. Soya 
based milk is mostly used in cases of intolerance for proteins of 
cow's milk. 
The content is given in terms of ready for use liquid (ngjml) or 
caloric intake (ng Sejkcal) to allow mutual comparison between powder 
and liquid formula and calculation of mean daily intake. 
The powdered milk and soya based infant formula have a mean dilution 
factor of 15 
.:<: 1.% and a mean caloric value of 0.7 + 0.11 kcaljml 
(n=13) • A mean concentration of 5.3 ± 4.1 ng Se/m1 and a median 
value of 4.7 ng Sejml are calculated for the milk based infant 
formula while in terms of caloric intake a mean value of s.o .:<: 6.1 
ng Sejkca1 and a median concentration of 6.5 ng Sejkcal are obtained 
The formula for therapeutic use after appropriate dilution, have a 
mean concentration of 9.9 ± 9.3 ng Se/ml and a median value of 8.5 
ng se;ml while in terms of caloric intake they revealed a mean 
value of 12.9 ± 1.2.2 ngjkcal and a median concentration of 12.3 ng 
Se/kcal. 
As human milk usually serves as the standard of comparison for the 
nutritional adequacy of commercial infant formula, the selenium 
content of mature human milk in Belgium has been determined in an 
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earlier study (16). 
The selenium contents of eleven milk samples are summarized in table 
2. Processed milk has a mean selenium concentration of 5.9 ± 0.3 
ngjml when a 1/3 dilution of cow's milk for infant use is taken into 
account ,providing 19 z 5.1 ngjkcal. 
The selenium content of thirty-five samples of beikost are summa-
rized in table 3, together with five samples of cereal infant formu-
la. The mean selenium content in caloric terms of cereal infant 
formula is 9.7 + 8.1 ngjkcal. 
Table 4 reviews the selenium content of the different infant food 
classes in Belgium. 
DISCUSSION 
The mean 5.3 ngjml as well as the median value 4.7 ngjml of the 
selenium content in milk based infant formula after appropriate 
dilution are lower than the mean value of 9.9 ngjml for mature human 
milk in Belgium (16). Only one milk infant formula has a higher 
selenium concentration than the mature human milk, namely Beba of 
Nestle which contains 13.6% maize. 
The mean selenium content 9.9 ± 9.3 ngjml of milk formula for thera-
peutic use is the same as the mean selenium content of mature human 
milk, which is merely due to the high concentration found in the 
Realmentyl formula. The median selenium content (8.5 ngjml) and the 
selenium content in caloric terms (12.9 ± 10.2 ngjkcal) are lower 
than in the corresponding values for mature human milk in Belgium. 
To calculate the mean daily intake of selenium by infants, we used 
two sets of mean caloric intake. The first set was used to calcu-
late the daily intake at 3 to 6 months as presented by Whitehead et 
al. (22) who made a statistical analysis of energy intake data 
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collected in Cambridge, (U.K.) and data derived from a literature 
survey of cross-sectional food energy intakes of infants from Cana-
da, Sweden, the U.K. and the u.s.A.. The second set was used to 
calculate the daily intake at one month and was taken from Ziegler 
and Fomon (24) who carried out a food intake and growth study. They 
found a value of 342 kcaljday ± 80 for infants of 2-3 months, which 
corresponded very well with the value 480 to 580 kcaljday claimed by 
Whitehead et al. (22). 
The mean caloric intakes at 1,3 and 6 months of age were combined 
with the median selenium content and the range in selenium content 
of milk, soya and cereal infant formula, cow's milk and human milk. 
The results are summarized in table 5. A possible influence of the 
difference in energy density of the food consumed on the intake has 
not been taken in account. The recommended intake of 10-40 ugjday 
(6) is met only by the median cow 1 s milk intake (10,8 ugjday) at six 
months of age, and approached by the median human milk, the median 
milk infant formula for therapeutic use and the soya based formula 
at six months of age (7.8-8.6 ugjday). The median intake by milk 
based infant formula (4.2 ugjday) and cereal infant formula (5.3 
ugjday) at six months of age is a factor two too low. Since great 
variability of selenium concentrations exists for the different 
foods, 
Of the 
individual formula may give an adequate intake of selenium. 
milk infant formula, only the Beba and Realmentyl formula 
will follow up the recommendations of the Food and Nutrition Board, 
while only a few others approach the recommendations for children 
aged six months. 
From table 3 it can be seen that introduction of other milk products 
will mostly not improve the selenium intake by infants, because only 
yoghurt has a higher selenium content compared with human milk. 
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In table 6 we compared our values with literature data. All litera-
ture data,except one (3),prove that ~~e selenium intake of infants, 
fed commercial infant formula are lower than the selenium intake of 
breast-fed infants. 
Since different reports (10,20) claimed that serum selenium concen-
tration is age-dependent with a decrease in early infanthood, 
commercial infant food can lead to a further drop in serum selenium 
concentration, especially in some clinical cases (1). 
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Table 1. Selenium content of processed milk 
Manufacturer Product 
!.Milk based formula 
1,1 Humanised milk 
Guigoz Nativa 
Nativa 1 
Milupa Neomil (c) 
Nestle Alprem(c) 
Almiron 
Almiron 
Almiron M2 
1,2 Soft milk 
Nestle Beba (b) 
Nutricia Nutrimel 
1,3 Acidified milk 
Nestle Pelargon 
Prodieton 
Nutricia Bebiron 
2.soya based infant formula 
Nutricia Nutri-soya 
J,Milk infant formula for therapeutic use 
De Bouronville Biosorb 
Drink 
Eaton Vivonex 
Head Johnson Nutramigen 
Pregestimyl 
Nestle CFI 
Al 110 
A! fare 
Nutricia Pepti-Junior 
Amirige 
Nutri 2000 
Roussel Presondyl 
Realmentyl 
(a) 
kcalfml 
0.70 
0,70 
0.76 
0,70 
0.77 
0,77 
0.77 
0. 71 
0.34 
0,77 
0.62 
0.72 
0.74 
1 
1 
0,69 
0.67 
0,37 
0.67 
0,79 
0.70 
0.036 
1.0 
0.7 
1.3 
Selenium content ±SD(n) 
(a) 
ngjml 
1.3± 0,8(2) 
0,6± 0.4(3) 
4.8± 2.2(3) 
4,6± 2.2(3) 
4.9± 0.4(3) 
2.3± 0.4(2) 
3.9± 0.1(3) 
16,8± 3,1(3) 
4.6± 2.2(4) 
7,3± 0,8(3) 
6.3± 1.3(3) 
6.0± 2.3(3) 
8.9± 2.3(2) 
5,8± 4.6(2) 
7.7± 2.7(3) 
8.5± 2.4(3) 
9.7± 1.8(7) 
12,8± 2.6(3) 
10.3± 0.9(3) 
4.7± 1.1(3) 
8.8± 0.7(4) 
2,7± 0.4(3) 
1.3± 0.4(3) 
2,8± 0,4(2) 
36± 5.0(2) 
ngfkcal 
1.9 
0.9 
6,3 
6.6 
6.4 
3.0 
5.1 
23.7 
13.5 
9.5 
10.2 
8.3 
12,0 
5.8 
7.7 
12,3 
14.5 
34,6 
15.4 
5,9 
12.6 
75,0 
1.3 
4.0 
27.7 
----------------------------------------------------------------------------------(a) ready for use liquid after appropriate dilution 
(b) powder contains 13,6% maize 
(c) for clinical use only 
Table 2. Selenium content of processed milk 
Salllple Number 
of samples 
Whole milk grade(UHT) 3 
Full cream milk(UHT) 2 
Semi skimmed milk(UHT) 4 
Skimmed milk(Uh~) 2 
kcaljml 
0.6 
0.6 
0.45 
0.34 
Selenium 
ng/ml 
8.7 + 0.8 
9.5 + 0.7 
8.4 + 1.7 
8.8 + 1.1 
content 
ng/kcal 
15 
16 
19 
26 
Tabel 3. Selenium content of cereal infant formula and beikost 
Sample Number 
of samples 
l. Cereal infant formula 
Mixed cereals based 
Guigoz-Florigor 2 
Nestle-Sinlac 2 
Nutricia-Bambix 2 
Rica based 
Nestle-Cerelac 2 
Wheat based 
Nestle-Cerelac 2 
2. Beikost 
Skimmed cheese 8 
Semi-skimmed cheese 5 
Yoghurt 3 
Fruit porridge 10 
Strained baby foods 9 
Selenium content 
kca1jg ng; g ngjkcal 
(a) (a) 
3.9 44+ 10 11.3 
3.9 14+ 4 3.6 
3.7 84+ 23 22.7 
4.4 36:t 11 8.2 
4.3 112: 3 2.6 
(b) (b) 
1.4 .22:t 7 16 
1.2 19.:!: 8 16 
0-6±. 0.3 17+ 9 37+ 34 
o. 9:t 0.15 8.9+ 6.8 9. 9.±_ 7.7 
0. 67± 0.17 10.:!: 6 15 
--------------------------------------------------------------------(a) dry weight 
(b) wet weight 
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Table 4 Selenium content of different infant food classes in Belgium 
Type of food 
Milk based formula 
Soya based formula 
Milk infant formula for 
therapeutic use (b) 
Mature human milk(c) 
Processed cow's milk 
Cereal infant formula 
n 
12 
1 
11 
24 
11 
5 
selenium content 
ng/m1 (a) 
5.3.:!:. 4.1 
4.7 
0.6-16.8 
8.9+ 2.3 
9.9+ 9.3 
8.5 
1.3-36 
9.9+ 2.6 
9.3-
5.8-15.9 
5.9+ 0.3 
9.0-
6.4-10.0 
38:':: 29 (d) 
36 
11-84 
mean + SD 
mediall 
range 
ng/kca1 (a) 
8.0+ 6.1 
6.5 
0.9-23.7 
12.0 
12.9+ 10.2 
12.3 
1.3-34.6 
14.1 
13.2 
8.3-22.7 
18+ 5 
16.6 
13.3-27.9 
9.7+ 8.1 
8.2 
36-22.7 
(a) ready for use liquid after appropriate dilution, for processed 
cow's milk a 1/3 dilution was taken 
(b) amerige not included, because it is used as supplement (lg for 
100 m1) 
(c) reference 16 
(d) selenium content in ngjg dry weight 
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Table 5. Mean daily selenium intake for Belgian infants (ug;day) 
Type of food 
Milk based formula 
soya based formula 
Milk infant formula for 
therapeutic use 
Mature human milk 
Processed cow's milk 
Cereal infant formula 
Months of age (caloric intake in kcaljday) 
a 
6 (650) 
a 
1(460) 
a 
3 (545) 
Daily selenium intake 
mean 
(range) 
3.0 3.5 
(0.4-10.9) (0.5-12.9) 
5.5 6.5 
5.7 6.7 
(0.6-15.9) (0.7-18.9) 
6.1 7.2 
(3.8-10.4) (4.5-12.4) 
7.6 9.0 
(6.1-12.8) (7.2-15.2) 
4.5 
(2.0-12.4) 
4.2 
(0.6-15.4) 
7.8 
8.0 
(0.8-22.5) 
8.6 
(5.4-14.8) 
10.8 
(8.6-18.1) 
5.3 
(2.3-14.8) 
(a) from reference 23, 24. 
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Tabel 6. Estimated daily intake of selenium (ugjday) for infants 
Country 
Belgium 
Germany 
(West) 
Average 
intake 
7.2 
3.5 
9.0 
4.5 
22 
8 
Japan 17 
New Zealar..d 5 
2 
Scotland 35 
18 
Spain 4.5 
10 
7 
USA 10 
72 
7 
32 
13 
12 
9.5 
8.5 
Age Specification 
(months) 
3 
3 
3 
3 
2 
2 
5 
1 
1 
3 
3 
5-6 
5-6 
5-6 
3 
3 
breast milk 
milk based formula 
bottle-fed cow's milk 
cereal infant formula 
breast milk 
cow's milk 
breast milk 
breast milk 
bottle-fed cow's milk 
breast milk 
milk infant formula 
breast milk 
milk infant formula 
bottle-fed cow's milk 
breast milk 
milk infant formula 
ref. 
this study 
this study 
this study 
this study 
11 
11 
7 
14 
14 
2 
2 
3 
3 
3 
19 
19 
formula diets (700 kcaljday) 
0-6 
0-6 
0-6 
0-6 
0-6 
meat-based 
casein-based 
milk- and soya-based 
soya-based 
milk-based 
23 
23 
23 
23 
23 
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ZlNC CONTENT OF INTRA VENOUS 
SOLUTIONS 
M. VAN CAILLIE 
I. LUIJENDIJK 
H. DEGENHART 
]. FERNANDES 
Department of Pediatrics, Sophia Children's Hospital, 
Erasmus Uniwrsity, Roucrdam, The Netherlands 
Su77r71W.TY The zinc, copper, and selenium content 
of commonly used intravenous solutions, 
aminoacid solutions, and fresh·frozen plasma was deter-
mined by atomic absorption spectrometry and fluori-
metry. Very small amOllJ:!.ts of copper and variable, but 
substantial, amounts of zinc were present in all solutions 
tested. Zinc contamination could have come from the 
rubber stoppers for the glass bottles. Selenium could not 
be detected in any of the solutions. Fresh-frozen plasma 
contained high levels of zinc and physiological amounts 
of copper and selenium. 
INTRODUCTION 
BECAUSE zinc and copper deficiency were reponed in 
patients on total parenteral nutrition (T.P.N.) for pro-
longed periods, 1- 5 it has been repeatedly advocated that 
aminoacid solutions be supplemented by trace metals. 3-7 
Often the tacit assumption is that these solutions contain 
only very small amounts of essential trace elements. We 
report here the zinc, copper, and selenium content of in-
travenous solutions commonly given tO patients on T.P .N. 
MATERIALS AND METHODS 
Several bottles of eacll of various intravenous solutions were 
cllo= at random from the Children's Hospital pharmacv. 
Each bottle was carefully opened and sampled to avoid coO-
THELANCET,JULY22, 1978 
tamination. Fresh-frozen plasma being given to patients on 
T.!".N. was sampled at random. 
Seven rubber stoppers, used for glass bottles containing dif-
ferent intravenous solutions, were weighed and cut into pieces 
with a zinc-free surgical scalpel. A piece of each stopper was 
weighed, soaked. and heated to 200"C for 2 h in nitric acid 
of high purity (Merck, 65%). The zinc and copper content of 
the 50lutions so obtained was determined in duplicate by ato-
mic absorption Spectrometry. The selenium content was deter-
mined in duplicate by the fluorimetric method of Watkinson." 
RESULTS 
The zinc, copper, and selenium content of aminoacid 
solutions, dextrose 5%/NaCl 0-45%, NaCl 0-9${., sterile 
water, and fresh· frozen plasma is· shown in the table. 
Zinc levels were the most inconsistent of the elements 
studied, the variability being high not only between but 
also within batches. The highest zinc levels were found 
in glucose-containing or fructose--containing aminoacid 
solutions. 
All rubber stoppers contained a significam amount of 
zinc. Values ranging from 9-2 to 29-4 with a mean of 
15-2 mg zinc/g rubber were found. The results were 
fairly consistent for a given manufacturer. 
DISCUSSION 
This study shows that most intravenous solutions 
commonly given to patients on T.P.N. contain very low 
levels of copper, minute quantities of selenium, but sub-
stantial amounts of zinc, and that fresh-frozen plasma 
contains high zinc levels and physiological levels of cop-
per and selenium. Since normal values in our laboratory 
for serum zinc and copper and for plasma-selenium are 
117±20 iJ-g/dl, 122±22 1-'-g/dl, and 9-8±1 iJ-g/dl respec· 
tively, plasma infusions must be considered a source of 
essential trace metals. 
The high zinc content found in the rubber stoppers 
used in the glass bottles confirms the findings of Jetton 
et a!., who have shown that zinc can leach out of these 
stoppers into the solution.9 Theoretically, the extent of 
TRACE ELEMENT CONTENT Of tNTRAVENOl'S SOLllTIONS 
Solutions 
TPN sO/Mtions. 
"Vamin glucose' (Virrum) 
'Yamin fruaosc' (Yitrum) 
"Yamin N' (Yitrum) 
'Amine::~' (Astra Ned) 
'T rophysan" {Egic) 
Olh.:rs• 
Dextro~ 5',(./NaQ 0-45<;(. 
Naa 0-9<;,:, 
Sterile water 
Fresh-frozen pl~m<4 
• All soluuons w~ obta.tned from the same manufae1urer. 
tNot detectable bv the method used. 
:l:Results for fres.h~frm:en plasma given as mean:!: ~.1). 
No. 
4 
4 
3 
3 
/.•n~ 
~:·/idl: 
M~ 
81·5 
57 
10 
27 
6-5 
2·1) 
191 
·,± 15) 
Ran~ Mean 
,,· 1111 _\-~ 
}'1-43 
2'1-<JS 3-3 
5-lt-17 1 
57-153 
4--56 2-7 
7·4-9 
' 1-7-3-3 
113 
:. ~0) 
Copper 
(:•g/dl) 
R..!ngc 
3-5-4-2 
3-4 
3-4 
Not-+ 
2-3-3 
1>·1-9 
"' 
Selenium 
(fLg/dl) 
<0·1 
<0-1 
<0 -1 
<0-1 
<0-1 
n 
\ ±0-6: 
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contamination depends on variables such as duration of 
exposure of the solution to the ~topper and shaking dur-
ing transport and storage; these can largely account for 
the inconsistent zinc levels. The largest amounts of zinc 
were detected in the carbohydrate-containing amino-
acid solutions probably because factors specific to these 
solutions, such as aminosugar complexes, slowly formed 
bv the Maillard reaction and well known chel:nors, 10 
~ay increase the amount of zinc kached out. 
The lowest amount of trace element contamination 
was observed in aminoacid soi'.ltions. The copper con-
tent was negligible in all solutions tested. Greenc2 
reported 2-7 ·2 f.'g zinc/dl 'Freamine' and Okada ... 
2-8 fig zinc/dl 'lspol' 12ft-. and 'Aml-U'. We found very 
low zinc levels in •Aminess' but james ct aJ.ll found 
117·5±38·9 p.g zinc/dl 'Amlnofusin 850'. Protein hyd-
rolysates also contained high levels of zinc-Jetton et al. 
found 300 [.(g zinc/dl 'Hyprotigen'9 and Greene reponed 
14-60 f.'g zinc/dl 'Aminosol' and 'Amigen'.2 These pro-
tein hydrolysates, as well as the 'Yamin' solutions, could 
provide adults and infants on T.P.N. with their basal 
daily requirement (20 p.g and 40 f.'S zinc/kg body weight 
respecrivcly12), but may still be insufficient for some pa-
tients. It is thus imperative to know not only the trace 
74 
dement composition of intravenous solutions (it should 
be stated on the label) but also the zinc status of the pa-
tient, so that one could, if necessary, add trace metals to 
the solution in order to correct for previous deficits and 
for current gastrointestinal and urinary losses/ as well 
as provide for daily basal requirements. 
\V,'c thank M~ A. Kondand ond Nlr., H. de Leeu"' (or technic:~.! "-'· 
\i,tance, Mi'~ C. van Thid and Mi,~ G. Schouten for >e<:ret:mal help, 
and Mr B. Gruat'ma and Dr R. G. l'ear>.c lor thc~rsugge.tion,. 
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Selenium Status of Infants on Nutritional Support 
M. VAN CAILLIE-BERTRAND. H. J. DEGENHART 
and J. FERNANDES 
Department of Paediatrics. Erasmus University. University Hospitul. 
Sophia Children's Hospital. Rotterdam, The Netherlands 
ABSTRACT. Van Caillie-Bertrand. M .• Degenhart. H. j. and Fernandes. j. (Department of 
Paediatrics, Erasmus University. University Hospital. Sophia Children's Hospital, Rotter-
dam. The Netherlands). Selenium status of infants on nutritional support. Acta Paediatr 
Scand 73:816, 1984. 
We investigated the selenium status of 5 infants while on nutritional support. After 4 weeks of 
parenteral nutrition a significant fall in plasma selenium concentrations was observed 
(mean± SD: 0.8±0.5 !Jg/dl: nonnal for this aJ:e: 3.6±0.9 !J.g/dl). In 1 infant the decline in 
sclenium value occurred simultaneously with a transient rise in transaminases. A parallel but 
delayed decrease in red blood celi-J:Iutathione peroxidase activity was seen in 3 patients. After 
reintroduction of enteral foods. the selenium levels increased progressively to and reached 
control values after 6 wet>ks, 4 and 5 months resr;:•ctively in 3 patients. su~gesting that the 
selenium requirement on TPN was not met. We consider it essential to provide lon~erm TPN 
patients with physiological amounts of selenium in order to prevent the progressive develop-
ment of a deficiency state. Key words: Selenium. erythrocyte gluJathionc peroxidase activity, 
infants, nu.trilional support. 
In those patients on total parenteral nutrition (TPN) who receive little or no additional 
nutrition by mouth for months or even years, clinical deficiency states may appear that 
otherWise are rarely seen (I). The relevance of selenium deficiency was first suggested by 
Van Ry et aJ. (2). when they observed a patient on TPN who developed tenderness in the 
thighs with inability to walk. This syndrome responded to selenium supplementation 
aJone. Later Fleming et al. (l). and Johnson et al. (3) described in similar patients a 
progressive cardiomyopathy very comparable to Keshan disease. Epidemiological studies 
in China had aJready shown that selenium supplementation prevents the occurrence of a 
fatal cardiomyopathy in children living in selenium deficient areas (4). The occurrence of a 
sudden cardiac arrest in 2 infants after 18 and 9 months of TPN respectively, prompted us 
to investigate the selenium status of 5 infants while on nutritional support. 
PATIENTS AND METHODS 
The selenium status of five infants was studied. They received TPN for periods ranging from 14 days 
to 10 months. thereafter supplemented with a naso-gastric drip with an elemental diet and or.;~] foods. 
The indications for TPN were massive small-bowel resection (3}, protracted diarrhea of infancy (I) 
and meningitis with severe malnutrition (I). The age at which TPN wa::. begun ranged from I to 4 
months. The regimen used for TPN was similar to that reported previously (5). The infusate consisted 
of three basic solutions: (l) Yamin. composed of amino-acids. glucose and electrolytes. Cl lOW 
lntralipid containing the fat emulsion, (3) 15% glucose. Daily requirements of vitamins and miner.ils 
were added to the basic infusions and fresh frozen plasma was given twice a week. 
Age matched controls were 1::?. infants (0-\::?. months). all receiving a humanized cow'::. milk infant 
formula (Almiron®-Nutricia) who had to undergo minor operations. diagnostic procedures or were 
seen at a last follow-up visit after an acute illness. All were growing well and had a height and weight 
>P3 for age. 
The glutathione peroxidase activity of the red cells was measured at 30°. using butylhydroperoxide 
as described by Paglia & Valentine (6). The plasma selenium concentrations were determined by the 
method of Watkinson (7). 
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Fig. I. Plasma selenium concentrations in infants after 4 weeks on nutritional support. The shaded 
area indicates the reference range. 
Fig. 2. Selenium concentrations of plasma and glutathione peroxidase activity in erythrocytes in 
patient 2 during TPN and after reintroduction of enteral foods. Shaded areas indicate the reference 
range. 
RESULTS 
All five infants showed a satisfactory weight gain while on TPN. The plasma selenium 
concentrations during nutritional support (TPN followed by elemental diet and parenteral 
supplementation) are shown in Table I and Fig. I. After the introduction of enteral foods 
the selenium levels rose progressively and in 3 infants reached normal levels after 6 weeks. 
4 and 5 months respectively. In the fourth patient. the level had risen from 0.4 J..lg/dl to 1.5 
J..lg/dl4 weeks after discharge when he was lost to follow up. The fifth infant who received 
first an elemental diet and thereafter a Soya feed. had 4 weeks after resuming oral intake 
still a very low selenium level: 0.4 !J.g/dl. 
Table I. Plasma selenium levels in infants on nutritional support and age-matched control 
subjects 
Patients 
I 
2 
3 
4 
5 
Controls 
No. 12 
Plasma selenium concentrations (f.!g/100 ml) 
Week ofTPN 
2 4" 
2.2 2.1 0.9 
1.4 1.0 0.5 
0.3 0.4 
1.6 
1.1 <0.4 
3.6±0.9 (mean±SD: as shown in Fig. I) 
" Supplemented with elemental diet. 
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On oral foods 
0.5 
4.0 
1.5 
5.4 
5.6 
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A parallel but delayed decline in erythrocyte gluthatione peroxidase activity was seen in 
3 patients: from 25 to 9 U/g Hb. from 34 to 15 U/g Hb. and from 17 to 14 U/g Hb. Although 
suggestive these values were not significantly different from those observed in age 
matched controls (mean ± SD: 16±4 U/g Hb). In infant 2. the erythrocyte glutathione 
peroxidase activity rose progressively with the selenium level after the reintroduction of 
enteral feeding (Fig. 2). 
Liver function tests were periodically determined during TPN. Only in patient I we 
noted a transient elevation of the transaminases without hyperbilirubinemia. This coin~ 
cided with the lowest selenium level in this patient. 
DISCUSSION 
We showed a progressive. steady and significant decline with time of plasma selenium 
values in 5 infants while on nutritional support. This occurred despite the weekly adminis-
tration of fresh frozen plasma which contains trace amounts of this metal (8). The selenium 
content of the usual solutions given in TPN (9) is extremely low: it is consequently not 
possible to maintain in those patients plasma levels within age matched range without 
supplementation. 
We confirmed the existence of a positive correlation between declining plasma selenium 
levels and glutathione peroxidase activities in the red blood cells ( 10). Moreover in patient 
2. the glutathione peroxidase activity progressively rose with increasing selenium levels 
after reintroduction of enteral foods. This suggests that the selenium requirement was not 
met during the period on nutritional support. 
It has been shown in China that an adequate selenium intake prevents the occurrence of 
the fatal cardiomyopathy known as Keshan disease. It has also been shown in animals that 
adequate selenium levels protects liver membranes against diquat and paraquat poisoning 
(II). The transient elevation of transaminase occurring simultaneously with the lowest 
selenium level in one of those five infants. as in the child reported by Kien & Ganther (10), 
is therefore disturbing. As an integral part of the enzyme glutathione peroxidase (12). 
selenium provides an efficient means of defense against the build-up of peroxides which 
otherwise are able to damage cell membranes and macromolecules (13). It is highly 
probable that a deficiency will not become apparent unless a coexisting vitamin E 
deficiency or a special stress (e.g. an infection) occurs. 
We consider that one should not wait until clear-cut deficiencies have developed but 
should aim to maintain plasma levels within the physiological range. recognising the fact 
that selenium in man is age dependent. The amount that should be supplemented is 
difficult to define as the optimal requirements are not exactly known. while selenium in 
larger doses is toxic. A conservative estimation is 2 !lg/kg/day for infants. 10-20 !lg/day for 
children (l4) and 50-100 !lg/day for adults(!, 15). 
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TRACE METALS IN CYSTIC FIBROSIS 
M. VAN CAILUE-BERTRAND. F. DE BIEVILLE. H. NEIJENS. K. KERREBIJ:-.1. 
J. FERNANDES and H. DEGENHART 
From the Department of Paediatrics. Erasmus Unil'ersiry and Unil"('rsiry Hospiwi/Sophiu Childf!•n's Hospirul. 
Rot!erdam. The ,'1/eth(•r/and.,-
ABSTRACT. van Caillie-Bertrand. M .. de BiCville. F .• Ncijen~. H .. Kerrebijn. K .. Fer-
nandes. J. and D~enhart, H. {Department of Paediatric:., Erasmus l'niversit_y and Universit)' 
Hospital. Rotterdam. The Netherlands). Trace metals in c~·stic librosis. Acta Paediatr Seand. 
7!:203. 1982.-8erum zinc and copper concentration, 24 hrs urinary zinc and copper 
excretion. pla-.m.a selenium and red blood cell 1-!iutathione peroxidase activit)· were measured 
in 13 cystic fibrosis patients aged 6 to 15 years. The mean serum zinc ,-alue ±S.D. (17.3 
!Lmolll ±4.6) did not differ from that of the control group 117.9 !J.mol/1 ±3.1). Urinar)· zinc 
excretion in 12 out of 13 patients wa..-. within the normal r::mf_:e 11.53-13.8 ~-tmol/24 hrs). The 
mean serum copper ±S.D. (23.8 ~-tmol/1 ±4.2) was not sif!;nilicantl~· elevated as compared to 
the. value found in the control group (I9.2 p.mol/1 ±3.5l. but 4 children, includinf_: I with 
documented portal hypertension, showed an urinar~· copper excretion >0.94 !J.mol/2~ hrs 
I normal: 0.16-0.80 pmol/24 hrs). Mean plasma selenium± S.D. (0.84 ,umol/1 ± 0.25) wa..~ 
significantly reduced a~ compared to the control )!roup I 1.0 ,umol/1 ± 0.!5) (p<0.05). The 
correlation between selenium concentration and RBC elutathionc peroxidase acth·ity was 
si)!llificant (p<O.Ol). A neeativc correlation was abo found between plasma selenium and 24 
hrs faecal fat excretion (p<O.OS). It is concluded that CF children with severe d~·sfunetion of 
the exocrine pancreas are at increased ri~k to develop symptoms of subclinical or manirest 
zinc and/or selenium deficiency. Appropriate supplementatiou should thererore s~·stematicall~· 
be considered. 
KEY WORDS: Trace metals, zinc, copper, selenium. elutathione peroxidase, C)"Stic librosis 
Malabsorption is one of the main features of 
cystic fibrosis (CF). In spite of an adequate 
supply of calories. vitamins and pancreatic 
enzymes some patients fail to grow. There is 
now ample evidence that certain cases of nu-
tritional dwarfism and retarded pubertal devel-
opment are associated with zinc deficiency 
and that the administration of zinc normalizes 
growth and development (1). Not only zinc 
has been shown to be essential for man but 
also (among others) copper (2) and recently 
selenium (3). Animal models have shown that 
absorption of trace metals proceeds most effi-
ciently in the proximal small intestine: prob-
ably mediated by specific ligands present in 
pancreatic secretion and/or mucosal cells (4). 
Children with exocrine pancreatic insufficien-
cy. as observed in CF. might therefore have 
impaired absorption and secondary deficiency 
of these essential micronutrients. The purpose 
of this study was then to determine whether 
children with CF are at risk to develop defi-
ciency of zinc. copper and selenium. 
MATERIALS AND METHODS 
Thirteen patients with CF. aged 6 to 15 years were stud-
ied. While on a high protein, moderate fat intake all had 
severe steatorrhea and therefore received pancreatic re-
placement therapy. Eleven patients had failure to thrive. 6 
had severe pulmonary disease. Only I had documented 
portal hypertension: 12 other patients did not have clini-
cal evidence of liver disease and none was jaundiced. 
Zinc and copper concentrations in serum, 2~ hours 
urine and pancreatic preparations were measured in dupli-
cate by atomic absorption spectrometry. Plasma selenium 
concentrations and selenium content of pancreatic prep-
arations were detennined by the fluorimetric method of 
Watkinson (5). The glutathione peroxidase activity in the 
red blood cells {RBCl was measured after haemolysis. 
using the coupled test procedure with butylhydroperoxide 
as substrate as described by Paglia & Valentine 16). Fac-
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cal fat excretion was dete'rmined in duplicate during two 
collection periods of 72 hours and the results were aver· 
aged for each patient. For statistical analysis the Stu-
dent's t-test and. where appropriate, the Spearman rank 
correlation coefficient were used (J). 
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Fig. 2. Relationship between glutathione peroxidase activ-
ity and plasma selenium concentration. e. CF patients; 
0. age matched controls: D. normal adults. Spearman 
e:0.447, p<O.OI. 
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18 MO<>th• 
FiR. I. Plasma selenium concentrations in 
CF patients as compared to age matched 
controls. ~ indicates non:nal range (mean 
±S.D.). 
RESULTS 
Although the mean serum zinc concentration 
± S.D. (17.3 l'ffiO!Il ±4.6) found in the CF 
group did not differ significantly from that of a 
control group (17.9 !AffiOI/l ±3.1). 3 patients 
had a serum zinc level less than 2 S.D. below 
the mean of the control group ( < 11.8 ~moUi). 
In one of the three the urinary zinc excretion 
was markedly elevated (18.4 ~moU24 hrs). in 
the other two and in the remaining patients 
it was within the normal range (1.53-13.8 
l'ffiOI/24 hrs). 
The mean serum copper concentration ± 
S.D. (23.8±4.2 l'ffio!ll) was high, but not sig-
nificantly elevated when compared to that of 
the control group (19.2±3.5 l'ffiolm. Four CF 
patients. however. inducting the one with por-
tal hypertension showed a 24 hrs urinary cop-
per excretion greater than 0.95 f,l.mol. as com-
pared to none of 11 children with nonchole-
static chronic liver disease (normal range: 
0.16-0.80 l'ffiOI/24 hrs). One CF patient ap-
proached an excretion of 2.0 !J.moi/24 hrs. an 
amount we have seen in a patient with pre-
symptomatic Wilson's disease. 
Plasma selenium values (mean ±S.D.: 0.84 
~ol/1 ±0.25) were significantly reduced as 
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Table 1. Trace metal content of pancreatic preparations 
Selenium Zinc Nome Cop~r 
preparation (fj.g/g)d (!J.f!/g)J (fj.g/g) 
Lyopase®G Mean 0.42 {n=3) 44 (n,2J U (n=2) 
Range 
Cotazym®i' Mean 0.53 (n==5) 49 (n=6) 1.7 (n=7J 
Forte Range 0.44-0.59 46-51 !.3-2.0 
Pancreatic'" Mean 1.46 (n= 121 119 (n=8) 5.5 (n=8) 
grnin Range 1.29-1.71 118-122 1.9----8.0 
Pancreatic'" Mean 0.29 (n=6l 34.2 (n=6) 1.2 (n=6l 
capsule Range 
"' A. Christaens. Brussels. 
c Organon. Oss. 
'" Several. sources. 
0.20-0.42 27-40 0.8-1.4 
;; The weight of pancreatic preparations varies considerably. For the commercial preparations Lyopase® and Cotazym 
Forte® the weight was found to be approximately 2 g per powder capsule. resp. 610 mg per tablet. 
compared to the values found in age matched 
controls (mean ± S.D.: 1.0 f.U!!Oin ±0.15) 
(p<0.05). AU 7 children with a plaSma seleni-
um value <0.84 IAJllOl!l were followed. 4 of 
them up to 18 months after the first investiga-
tion. All patients except one remained below 
the normal range (Fig. 1). In 29 blood samples 
F...:cl fot _,..,r.,., (a/day) 
" 
" 
" 
10 
' 
0.5 0.75 1.0 
Pl......., Set.,;,..., ~ol/l) 
Fig. 3. Relationship between daily faecal fat excretion and 
plasma selenium concentration in 13 CF children. Spear-
man Q=0.587. p<0.025. 
(13 CF. 8 age matched controls. 8 adults) both 
the plasma selenium and the RBC glutathione 
activity were determined. In Fig. 2 the rela-
tionship between the two is shown. The corre-
lation appeared to be highly significant 
(e=0.447. p<O.OI). In Fig. 3 the relationship 
between faecal fat excretion and plasma sele-
nium concentration is shown. Five out of 6 CF 
children with a faecal fat excretion > 15 g/24 
hrs. had a plasma selenium value <0.84 
IAJllOlll. The negative correlation between fae~ 
cal fat excretion and plasma selenium concen-
tration was significant (Q=0.587. p<0.025). 
The only child who normalized his plasma 
selenium concentration during the period of 
observation showed a simultaneous decrease 
in faecal fat excretion from 25 g to 6.5 g fat! 
day. 
The trace metal content of the usual pancre-
atic preparations is shown in Table I. 
DISCUSSION 
CF children with severe exocrine pancreas 
dysfunction can be expected to develop symp-
toms of sub-clinical and/or manifest trace met-
al deficiency. Appropriate supplementation 
adapted to the patients' needs should then be 
considered. In concordance with the reports 
of others 0. 8) we have found sporadically a 
lowered serum zinc value. although without 
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decreased urinary zinc excretion as would 
arise from zinc malabsorption. One patient 
even showed an increased urinary loss of zinc. 
The finding of an increased urinary copper 
excretion in 30% of our CF children is disturb-
ing. Further studies will have to show whether 
CF patients excrete sufficient amounts of cop-
per with their bile as to prevent accumulation 
of copper in the liver. If not. it could increase 
the risk of secondary liver damage (9) and 
contribute to the development of liver cirrho-
sis. one of the late manifestations of CF. 
Selenium. a trace metal essential for man (3. 
lO. I 1. 12). appeared to be markedly reduced 
in 7 out of 13 GF children in this study. Seleni-
um deficiency causes widely different symp-
toms in various species. the young being the 
most susceptible. In the chick. selenium defi-
ciency results in "exsudative diathesis" and 
pancreatic atrophy. both subsiding with the 
administration of selenium (13). In the sub-
human primate. prolonged deficiency causes 
loss of body weight. listlessness. loss of hair 
and leads eventually to death (14). Very little 
is known about selenium metabolism in man. 
Children with kwashiorkor have been report-
ed to respond with increased weight gain on 
supplementation of the diet with selenium 
(15). In China. a cardiomyopathy known as 
Keshan disease. seems to be prevented with 
selenium { 10. 20). A clinical response to sele-
nium supplementation has also recently been 
described in a patient on total parenteral nutri-
tion. who complained of tenderness in the 
thigh muscles with inability to walk (3). 
Selenium functions as an integral part of 
glutathione peroxidase. an enzyme reducing 
(i.a.) toxic lipid peroxides. This enzyme has 
been found in almost every parenchymal tis-
sue investigated. As such. it protects cellular 
membranes from the effects of peroxides {16). 
In animals and in man (17. 18) the selenium 
content of the diet affects the activity of glu-
tathione peroxidase in the erythrocytes. 
The low dietary intake observed in the 
Netherlands where the soil selenium content 
is particularly low might explain our findings. 
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but not entirely. Indeed the selenium content 
of the usual pancreatic preparations appears 
to be unexpectedly high (from 0.2 to 1.7 !J.g-per 
gram) providing CF children with a supple-
ment of 10 to 20 1-1-g selenium/day. which repre-
sents the daily selenium dietary intake of a 
New Zealand resident (12). The low plasma 
selenium concentration and reduced RBC glu-
tathione peroxidase activity found in this 
study are most probably due to an impaired 
absorption of this metal in the presence of an 
excess of faecal fat. Supporting this view is 
the negative correlation between faecal fat ex-
cretion and plasma selenium levels. 
The selenium status of the human individual 
may affect the ability of the organism to pro-
tect biomembranes against oxidative challenge 
(16). We are unaware of any data on selenium 
concentration and/or glutathione peroxidase 
activity in the parenchymal tissues of children 
with CF. although Lloyd-Still in a recent pa-
per reported decreased blood levels in CF 
children (19). The fact that the activity of the 
human RBC glutathione peroxidase correlates 
closely with the selenium content in the diet 
(18). is indicative of the human requirement 
for this trace metal. Although selenium is a 
potentially toxic nutrient. supplementation in 
order to normalize plasma content may be 
justified on the conditions that plasma levels 
be monitored periodically. 
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CHAPTER V. WILSON'S DISEASE 
5.1 ASSESSMENT OF D-PENICILLAMINE THERAPY 
M.VAN CAILLIE-BERTRAND, H.J.DEGENHART, I.LUIJENDIJK, J.BOUQUET, 
M.SINAASAPPEL 
Department of Pediatrics,Erasmus University Rotterdam,University 
Hospital Rotterdam/Sophia Children 1 s Hospital,The Netherlands. 
SUMMARY 
Serum copper and zinc levels and 24 h urinary copper and zinc excre-
tion were determined serially from the onset of therapy with D-
Penicillamine (0-P) in 4 children with Wilson 1 s disease. The data 
show a progressive decrease of both serum copper and zinc levels in 
all patients. The urinary copper excretion gradually levelled off 
to approximately SO% of initial values, whereas the zinc excretion 
increased. Consequently the urinary zinc copper ratios increased 
with the duration of therapy. Decoppering was considered to be 
adequate as soon as a challenge with a test dose of D-P did not 
entail an increase in copper excretion. As for zinc its urinary 
excretion was further stepped up by the test dose. Zinc depletion 
was suspected in one patient who developed clinical features of zinc 
deficiency while on p-P maintenance therapy. Lowering the dose of 
D-P alleviated the symptoms as the urinary zinc loss decreased from 
4200 to 2200 ugj24h (64 to 19 umol/24 h), while the copper excretion 
remained largely unchanged.The data obtained indicate that D-P al-
ters the metabolism of both copper and zinc.The extent of this 
phenomenon is not only dose dependent but also related to the effi-
cacy of decoppering. In conclusion: one has to monitor both copper 
and zinc levels to assess the benefits of the therapy but also the 
risks of inducing manifest or subclinical zinc deficiency. 
Accepted for publication in Arch.Dis.Child. (December 1984). 
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The clinical manifestations of Wilson's disease are due to the 
accumulation of toxic amounts of copper in the liver, kidney, brain, 
cornea and other tissues. As first described by Walshe (1) and 
further confirmed by others (2), the treatment with D-Penicillamine 
(Dimethylcysteine) , combined with a low copper diet, has markedly 
improved the outcome of the disease. The ultimate prognosis 1 however, 
still depends on the age, symptoms and degree of tissue damage at 
the time of diagnosis (3,4). 
D-Penicillamine is an effective chelator of copper 1 is well absorbed 
from the gastrointestinal tract and promotes the urinary excretion 
of copper (1). Thus it allows the removal of the excessive amounts 
stored and it prevents further accumulation of copper. According to 
current recommendations (3,5) the treatment should be continued 
throughout life and the dosage adapted to the patient's tolerance. 
Practical guidelines are scanty however: a small dose might not be 
effective enough while a larger amount could be toxic (5). Other 
essential metals, especially zinc, may, by increased dosage, simul-
taneously be removed. To assess the efficacy of the therapy and 
avoid possible deficiency we studied therefore both zinc and copper 
values in serum and urine from the onset of D-P therapy in 4 chil-
dren with the hepatic form of Wilson's disease. 
PATIENTS 
The age of the children in this study was 5,3,7 and 10 years, 
respectively, when D-P therapy was started. Criteria for diagnosis 
(3) were 1) liver copper levels >325 ug/g dry weight 2)urinary 
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copper excretion > so ug 1 24h 3) abnormal radiocopper kinetics in 
64 
patients 1 and 2 (no significant incorporation of cu in ceruloplas-
min ) 4)low serum ceruloplasmin levels (<20 mgjdl) S)familial 
occurrence in patients 2, 3 and 4. None had Kayser-Fleischer rings 
or neurologic symptoms. Patient 1 presented with a chronic active 
hepatitis like syndrome, patient 3 with liver fibrosis, patients 2 
and 4 were asymptomatic siblings of known patients with Wilson's 
disease. None was jaundiced. 
THERAPEUTIC DESIGN 
Soon after confirmation of the diagnosis of Wilson's disease the 
patients were treated with D-P and a low copper diet was prescribed. 
The drug was administered in 3 doses given with the meals. The 
initial dose was 500 mg daily, except for patient 1 who received 300 
mg. This dose was maintained during the initial six months in 
patients 2, 3 and 4. After this induction period a challenge dose 
was given. This was equal to the maintenance dose +250 mg. 
Dependent upon the results obtained, the maintenance dose was 
increased or continued unchanged. 
METHODS 
Liver function tests were carried out by standard techniques. 
Serum and 24 h urine for zinc and copper assays were collected in 
metal free containers at monthly intervals during the first year and 
at bimonthly intervals thereafter. All metal analyses were perfor-
med in duplicate by means of atomic absorption spectrophotometry. 
RESULTS 
CLINICAL COURSE: All children were asymptomatic with normalisation 
of the liver function tests at the last observation. They did not 
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develop any neurological signs of the disease nor Kayser-Fleischer 
rings. While receiving 1 g of D-P daily patient 1, however,developed 
skin lesions seven months after the start of therapy. These lesions 
consisted of alterations in hair texture with hair 
loss,parakeratosis of the extremities and deep grooves at the foot 
soles. Urinary zinc excretion at that moment was 4180 ug zincj24 h 
(64.3 umolj24h). Reducing the D-P dosage to 750 mg, alleviated the 
symptoms while the 24 h urinary zinc excretion decreased to 2260 ug 
(34.8 umol), and the copper excretion remained largely unchanged 
(1200 ug/24 h) (19 umo1/24 h). 
COPPER AND ZINC DATA. Serum copper levels decreased steadily during 
D-P therapy: from 51 to 28 (8.0 to 4.4), 55 to 20 (8.7 to 3.1), 72 
to 12 (1 1.4 to 1.9), 64 to <10 ugjd1 (1 0.1 to< 15 umo1/1) in 
patient l,2,3,and 4 respectively. Serum zinc levels, initially 
high (mean: 175 ugjd1 (27 umo1/1), range 250 to 143 ugjd1 (38 to 22 
umol/1)) followed the same trend and reached the low normal range 
(mean: 83 ugjd1 (1 2.7 umo1j1), range: 79 to 87 ugjd1 (12 to 1 3.3 
umol/1)) during maintenance therapy. The lowest value (64 ugjdl 
(9.8 umoljl)) was seen in patient 3, 15 months after the onset of 
therapy. 
Urinary copper and zinc excretions are summarised in fig.l. With 
the exception of patient 4, copper excretion exceeded zinc excre-
tion, even on a relatively low dose of D-P (500 mg) at the onset of 
therapy.As treatment continued the urinary copper excretion decrea-
sed progressively to approximately 50% of initial values, whereas 
the urinary zinc excretion increased further. Consequently the uri-
nary zinc copper ratios increased with the duration of therapy as 
show in the table. 
At the end of the initial phase of treatment (thus usually after 
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more than six months therapy) a challenge dose of D-P resulted in a 
rise in zinc excretion. No further increase in copper excretion was 
then observed, suggesting that decoppering was adequate. During 
the initial phase of treatment, however, this challenge dose of D-P 
did cause a rise in copper excretion as shown in patients 3 and 4, 4 
and 5 months respectively after the onset of therapy. 
DISCUSSION 
The data obtained show that D-P alters the excretion of both copper 
and zinc in patients with Wilson's disease. The extent of this 
phenomenon is not only dose dependent but also related to the effi-
cacy of decoppering. A comparison of the dissociation constants for 
metal-penicillamine complexes shows a decreasing stability in the 
order Hg> CU> Ag> Pb> Ni> Cd> Zn> Co> Fe> Mn (8). Consequently more 
copper is excreted than zinc in the copper loaded patient at the 
beginning of therapy. As the mass of copper decreases, zinc having 
a lower affinity constant but a relatively high abundance, will then 
be excreted in greater amounts.Therefore the appearance of increased 
zincuria during a D-P challenge is of significance both to assessing 
the benefits of the therapy and the risks of inducing zinc as well 
as other trace metals deficiencies. 
The effectiveness of therapy is usually assessed by serial determi-
nations of transaminases, serum copper and 24h urinary copper excre-
tion (3,5,6) .Our observation confirms previous reports: in children 
as well as in adults, serum copper falls with 
ceruloplasmin bound fraction of serum copper 
time, as the non-
returns to normal 
(1,7). 24 h urinary excretion rises initially, but levels off to 
approximately 50% of the initial values ((600-1000 ug/24 h (9.5- 15 
umol/24 h)) during maintenance therapy. 
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Serial serum zinc and 24 h urinary zinc excretion, however, are not 
routinely measured. The figure shows that these determinations give 
important complementary information for assessing the adequacy of 
therapy. If decoppering has been effective the increase in zinc 
excretion is not accompanied by any significant increase in copper 
excretion when the patient is challenged by a larger dose of D-P 
If the challenge dose steps up copper excretion, however,a higher 
maintenance dose of D-P is indicated. This approach may help to 
improve the effectiveness of the treatment and thus prevent a par-
tial failure of the therapy. 
Owing to its non-specificity as a chelator,D-P may also affect other 
biologically important metals. Although in clinical use for more 
than 25 years, few data exist about the long term effects of D-P 
upon the homeostasis of essential trace metals other than copper 
(9). Our findings support a previous report claiming that zinc 
deficiency may occur during treatment with D-P if urinary excretion 
exceeds the zinc absorption rate (10), although this was not 
substantiated with balance studies. Some of the known side effects 
of the drug strongly suggest a zinc deficiency: skin lesions on 
pressure points, desquamations, 
wound healing, alopecia and 
glossitis and stomatitis (11). 
psoriatiform eruptions, delayed 
sometimes loss of taste acuity, 
Some of the toxic effects of D-P 
may be attributable to hypersensivity, others to the fact that D-P 
is an important antimetabolite of pyridoxine or to its direct action 
upon collagen (12). A few are almost certainly due to zinc defi-
ciency and possibly also to deficiencies of other essential trace 
metals. 
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Fig.l 24 h urinary zinc and copper excretion in patients 1,2 1 3 and 4 
according to D-Penicillamine dosage, from the onset of therapy and 
during steady state. 
conversion -traditional units to SI:copper 1 ugj24h = 0.01~ umol/24h 
zinc 1 ug/24h = 0.015 umo1/24h. 
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TABLE 24 h Urinary zinc copper ratios at onset of D-Penicillamine 
therapy and during treatment 
Patients 
1 
2 
3 
4 
Mean 
+ so 
start of treatment 
(N) 
0.63 (3) 
1.12 (4) 
1. 01 (4) 
1. 09 (3) 
----
0,98 (14) 
± 0,4 
After D-P 
challenge 
-
-
0.84 
0,88 
Steady state 
(N) 
2.18 ( 1) 
2.15 (2) 
2.33 (6) 
2.09 ( 16) 
----
2,17 (25) 
± 0.6 
After 0-P 
challenge 
2.88 
3.14 
3.64 
3.76 
5.2 ORAL ZINC SULPHATE FOR WILSON'S DISEASE 
M. VAN CAILLIE-BERTRANO, H.J. DEGENHART , H.K.A. VISSER , 
M. SINAASAPPEL AND J. BOUQUET 
Department of Pediatrics,Erasmus University Rotterdam,University 
Hospital Rotterdam/Sophia Children's Hospital, The Netherlands 
SUMMARY 
After initial decoppering with D-Penicillamine (D-P} the effect of 
oral zinc sulphate (3xl50 mgjday as a loading dose, 3xlOO mgjday as 
a maintenance dose) was evaluated after completion of 3 years thera-
PY in 2 children with clinically stable Wilson's disease.The course 
as judged by clinical, biochemical and histological parameters was 
satisfactory in both patients. The urinary copper concentration 
reverted to <SO ugj24h (1.26 umol/24h) and the serum copper concen-
tration decreased further during zinc sulphate therapy. In one 
child the rise in 24h urinary copper excretion observed after a 
challenge dose of D-P ( 20mg/kg) remained constant throughout the 
period of observation while the liver copper content fell from 1460 
ugjg dry weight at diagnosis to 890 ugjg dry weight at reevaluation. 
In the other patient, however, the liver copper content as well as 
the 24h urinary copper excretion after D-P challenge increased 
during the third year of therapy. 
We conclude that zinc sulphate is a low-toxic and well tolerated 
alternative for D-P. The quantity of zinc required to block copper 
absorption adequately, however depends greatly on not yet well 
identified individual factors. We recommend to restrict its use in 
patients who do not tolerate D-P well and suggest to monitor the 
treatment with a D-P challenge every 12 months and a liver biopsy if 
liver function deteriorates. 
Accepted for publication in Arch.Dis.Child. (December 1984). 
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The current treatment of Wilson's disease is to restrict copper 
intake and to promote the urinary excretion of this metal by the 
administration of an oral copper chelating agent, D-Penicillamine 
(1). Side effects and toxic reactions are frequently observed and in 
a few instances require to stop the therapy (2). Moreover non-
compliance is nowadays the major problem of this life long treatment 
and might be partially due to a psychological aversion to the taste 
of this drug. 
One may consider a different therapeutical approach; i.e. to inhibit 
the gastrointestinal absorption of copper by the administration of a 
copper binding agent. Substances such as carbacrylamide and potas-
sium sulfide (3) however turned out to be unsuccessful at maintai-
ning negative copper balance. 
The antagonistic action of zinc on copper absorption was already 
known for years in veterinary medicine (4) when in 1961, Schouwink 
described the same effect in two patients with Wilson's disease. One 
of them has since then been treated succesfully during 25 years with 
zinc (5,6). The observation that large doses of zinc can inhibit 
copper absorption was further confirmed in sickle cell patients 
(7), and recently in a well controlled balance study of 5 patients 
with Wilson•s disease (8). Zinc sulphate may thus be considered as 
a low-toxic and safe alternative to the classic therapy with D-
Penicillamine in patients unable to tolerate the latter drug. We 
describe here the experience with two such children, treated for 3 
years with zinc sulphate after an initial decoppering period with 
D-Penicillamine. 
PATIENTS AND METHODS 
The age of the children was 3 and 5 years when D-Penicillamine 
therapy was started and 4 and 8 years, respectively, when zinc 
sulphate was introduced. They were in stable clinical condition: 
Kayser-Fleischer rings, neurologic symptoms, jaundice and portal 
hypertension were absent. Patient 2 presented initially with a 
chronic active hepatitis like syndrome without splenomegaly, while 
patient 1 was an asymptomatic sibling of a patient known to have 
Wilson's disease. On admission both patients had elevated transami-
nases. Criteria for diagnosis were: liver copper level > 325 ugjg 
dry weight, urinary copper excretion > 80 ugj24h (1.26 umolj24h) 
before therapy, caeruloplasmin level < 20 mgjdl, abnormal radio-
copper kinetics (no incorporation of 64 Cu in caeruloplasmin) and 
familial occurrence in patient 1. 
Serum and 24 h urine for zinc and copper assays as well as liver 
biopsy specimens were collected in metal free containers. All 
metal analyses were performed in duplicate by atomic absorption 
spectrophotometry.The intravenous radiocopper test was performed 
according to a modification of a previously described protocol (9). 
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Cu (half life 12,7h) was used at a dosis of 0.03 mCi (6 millirem). 
Serum liver function tests were carried out at intervals of appro-
ximately three months.Liver biopsies were examined with transmission 
electron microscopy. 
The zinc therapy regimen involved the administration of oral zinc 
sulphate with the meals, 3xl50 mgjday initially, followed by a 
maintenance dose of 3xlOO mgjday (Zn S04.7H20 corresponding to 3 X 
34 and 3 X 22,5 mgjday of elemental zinc, respectively). During 
challenge tests with D-Penicillamine (20 mg/kg), zinc therapy was 
discontinued 3 days before the challenge. 
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RESULTS 
Figure 1 shows the course of serum copper values and 24 h urinary 
copper excretion throughout therapy in both patients. Initially 
serum copper fell after decoppering with D-Penicillamine to 28 
ugjdl (4.4 umoljl) and 19 ugjdl (3 umoljl) respectively and de-
creased further during oral zinc sulphate therapy. 24h urinary 
copper excretion was elevated at diagnosis.It increased (as expected) 
during D-Penicillamine therapy, but after this treatment was discon-
tinued, it returned to normal values for patients with liver di-
seases (<80 ugj24h or<l.26 umol/24h) when the oral zinc sulphate 
regimen was reinstituted. 
The liver function tests (e.g. transaminases), normalised after the 
initial decoppering period under D-Penicillamine and remained so 
during the first 3 years wit.~ zinc sulphate therapy. Table 1 shows 
the effect of a challenge dose of D-Penicillamine on 24 hr urinary 
copper excretion after 3, 15, 27 and 39 months of zinc therapy. 
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The disappearance rate of intravenously administered cu from the 
plasma in both patients measured at yearly intervals after the start 
of zinc therapy, showed little change and the curves obtained were 
consistent with the absence of copper accumulation. 
Light microscopy showed initially a diffuse steatosis in both pa-
tients and a periportal inflammatory infiltrate with perilobular 
fibrosis and hepatocellular necrosis in patient 2. 3 Years after 
zinc sulphate therapy the liver histology was greatly improved and 
in both patients virtually normal. The ultrastructural changes 
(electron microscopy) were still characterised by the presence of 
heterogeneous multivesiculated inclusion bodies (lysosomes ?) in the 
hepatocytes. The mitochondria showed varied shapes and sizes with 
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deterioration of a substantial part of the cristae. 
The liver copper content which was 350 ugjg dry weight after initial 
decoppering with D-Penicillamine in patient 2, rose to 1050 ugjg dry 
weight after 3 years of zinc sulfate therapy. In patient 1 the 
liver copper content decreased from 1460 ugjg dry weight at diagno-
sis to 890 ugjg dry weight at reevaluation. 
No side-effects were observed. 
DISCUSSION 
There is now good evidence that long term zinc sulphate therapy can 
maintain neutral or negative copper balance in patients with clini-
cally stable Wilson~s disease. Recently, Brewer et al (8} reported 
that pharmacological doses of oral zinc promote the faecal excretion 
of copper in D-Penicillamine treated Wilson's patients provided that 
the previously depleted total body zinc was restored. This view is 
supported by the normal liver function tests, by the reversion of 
the urinary copper excretion to normal, and by t.~e maintenance of a 
low serum copper concentration during 3 years of zinc sulphate 
therapy in both children described here. The small but consistent 
rise in urinary copper excretion after a challenge dose of D-
Penicillamine in patient 1 leads to the same conclusion. This is 
further confirmed by t.~e course of the histological picture in both 
patients and by the determination of the liver copper content in 
patient 1. 
The increase in liver copper content observed in patient 2, however, 
is disturbing and the absence of concomitant elevation of the tran-
saminases values remains unexplained. This rise may be due to a 
sampling error with respect to the initial biopsy. In fact, such 
errors are not unusual in fibrotic tissue (10). On the other hand, 
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the dose of zinc sulphate may not have been large enough to prevent 
some reaccumulation of copper in the liver. That this could have 
occurred at the end of 3 years therapy in patient 2 can be deducted 
from the rise observed in 24 h urinary copper excretion after the 
challenge dose of D-Penicillamine. One could then speculate that 
zinc promotes the synthesis of metallothionein, not only in the 
intestinal - but also in the liver cells. Metallothionein is known 
to have a higher affinity for copper than for zinc (11). Any copper 
escaping the blocking effect of zinc on absorption will probably 
be bound to liver metallothionein and this mechanism may temporarily 
protect the tissue against the toxic effect of free copper, explai-
ning the absence of symptoms observed.The quantity of zinc required 
to block the copper absorption adequately has thus to be adapted 
individually. 
No previous data on liver copper content of Wilson 1 s patients 
treated with zinc sulphate are known to us. Nevertheless, zinc sul-
phate has been shown since 1957 to be able to maintain a negative 
copper balance and a satisfactory clinical condition in several 
patients in the Netherlands (5) . It can therefore be considered as 
a low-toxic, low-cost and safe alternative for D-Penicillamine pro-
vided the dosage is adjusted to individual needs. The effect of a 
low copper diet and of a specific zinc dose on the individual copper 
absorption are indeed still poorly understood at this moment. As 
long as zinc sulphate has not been proven to be effective in all 
patients, we suggest to prescribe it only if D-Penicillamine is 
either not tolerated or not available. We recommend to perform a 
challenge with a test dose of D-Penicillamine every 12 months and to 
adapt the maintenance dose of zinc sulphate to the outcome. 
In case of doubt a liver biopsy is indicated. 
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As yet there is no clinical experience with zinc therapy in acutely 
ill patients with Wilson's disease. 
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Figure l: Serum copper and 24 h urinary copper excretion during D-
Penicillamine and zinc sulphate therapy in patients 1 and 2 as 
a function of time. 
Conversion-traditional units to SI: Copper 1 ug = 0.01~ umol; 
Zinc 1 ug =0.015 umol. 
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TABLE Urinary copper and zinc excretion after a test dose of D-Penicillamine 
Time since start Patient 1 Patient 2 
of treatment(months) Zn (ug/24 h) cu (ug/24 h) Zn(ugj24 h) Cu(ug/24 h) 
3 2060 250 1510 200 
15 2200 340 1730 320 
27 4400 200 1900 350 
39 3150 210 3700 960 
CHAPTER VI ~ FINAL DISCUSSION AND SUMMARY 
The aim of the studies presented in this thesis was to investigate 
some pediatric aspects of trace element metabolism .The effects are 
described of 1) inadequate trace element intake , 2) trace element 
malabsorption 
mine and 4) 
sulphate.Within 
,3) urinary losses during therapy with D-Penicilla-
zinc -copper interaction during therapy with zinc 
this general framework our attention was especially 
focused on the trace element selenium 1 whose essentiality was vir-
tually unrecognized at the beginning of these studies in l978.Much 
attention was also paid to the different aspects of zinc and copper 
homeostasis in Wilson's disease, which represents one of nature's 
experiments of trace element interaction .Several guestions,related 
to the treatment of this inherited metabolic disorder,had to be 
solved. 
In the initial phase of the study ,it was decided to establish 
within our laboratory the levels of plasma selenium in healthy 
individuals of different ages . Hardly anything was known about 
selenium. our studies confirmed and completed the scarce reports 
from New-Zealand 
creases steadily. 
and Germany ,that the plasma selenium level in-
When expressed on a logarithmic scale,it rises 
almost linearly with age. The values found in infancy were signifi-
cantly lower than the levels found in adults or in a group of older 
children, while younger children had intermediate levels.As to zinc 
and copper ,we found levels, in serum and plasma ,which were 
comparable (mean ~ SD) to those previously reported in the litera-
ture . Unforeseen sources of metal contamination (as vacutainer rub-
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ber stoppers) were looked for and eliminated We saw the characte-
ristic (physiological ?) decline in plasma zinc values at about 
three months of age in infants. It is ~~us mandatory, when one 
wishes to interpret a serum or plasma level of selenium, copper or 
zinc correctly, ~ot only to define the age of the child but also to 
use appropriate reference values.It is also advisable to define 
time, fasting state and possible stress. 
The nutritional aspects of selenium during infancy were further 
investigated.The importance of this aspect cannot be overemphazised, 
1 
to quote Henry A.Schroeder "The trace elements are more important 
in nutrition than are the vitamins,in the sense that they cannot be 
synthesised by living matter, as is the case with vitamins.Thus they 
are the basic sparkplugs in the chemistry of life". 
The selenium intake of healthy full term infants on breast milk, 
commercial formulas and nutritional support was evaluated. 
It was found that the selenium content of breast milk is highest in 
colostrum, subsequently declines and finally levels off after one 
month. The daily intake of infants in Belgium was calculated to 
average 8 ug ( 3.4 - 9.1 ug). Still lower was the mean daily intake 
of infants fed adapted formulas (3.8 - 6.2 ug), while infants fed 
undiluted cow's milk would receive 8.7 to 12.4 ugjday. 
The adequate and safe daily selenium intake for infants (10 to 40 
ugjday ) ,recommended by the u.s. Food and Nutrition Board, is thus 
not met in Belgium. This is reflected in the plasma levels, which 
are particularly low.These levels are not very far removed from the 
values found in children living in selenium deficient areas in China 
(mean ± SD : 1.7 ± 0.02 ugjlOO ml ) .Here, the incidence of Keshan 
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disease is estimated at 1/200 children.At present, there is no 
clinical disorder ascribed to a marginal deficiency. How important 
indeed is an adequate selenium supply in human health care ? To 
2 
quote Flohe : 11 Subacute deficiency existing for some time might 
induce a metabolic or histopathological change, which in turn will 
trigger a disease at some future time,when the deficiency itself may 
not be detectable anym.ore. 11 Although controversial, epidemiological 
studies with selenium supplementation in children with known 
selenium depletion and submitted to oxidative stress premature 
infants and patients with cystic fibrosis ) are urgently needed. 
More information on the toxicity of the various selenocompounds in 
man for this purpose is of utmost importance. 
The infants on 11 total 11 (?) parenteral nutrition are virtually de-
prived of significant amounts of selenium ,even if they are regular-
ly provided with fresh frozen plasma.The total amount given is 
insufficient to cover the requirement. The commercially available 
mineral solutions do not contain selenium at present. 
Our study on infants on nutritional support showed a significant 
fall in plasma selenium value after only 4 weeks on parenteral 
nutrition .A parallel but delayed decrease in red blood cell gluta-
thione peroxidase activity occured simultaneously. Noteworthy to 
say: in one infant the decline in selenium value occurred with a 
transient rise in transaminases. After reintroduction of enteral 
foods the selenium level increased progressively and reached refe-
rence values. This suggests that the selenium requirement was not 
met during nutritional support. We concluded that it is essential to 
provide longterm TPN patients with physiological amounts of selenium 
in order to prevent the progressive development of a deficiency 
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state. 
The influence of steatorrhea, and thus malabsorption, upon the trace 
element requirements was evaluated in 13 children with cystic fibro-
sis .We found adequate zinc levels in 11 and a possible zinc defi-
ciency in 2 patients.On the contrary ,the copper levels were 
as well as the urinary excretion of copper in some patients 
high, 
.The 
question has to be raised whether the biliary excretion of this 
metal is diminished in patients with cystic fibrosis and disturbed 
liver function. The plasma selenium levels were significantly re-
duced in comparison with an age-matched control group. Moreover we 
observed a negative correlation between the faecal fat excretion and 
the plasma selenium levels. Almost nothing is known about the 
mechanism of selenium absorption and this correlation was not 
described before. Since our publication in 1982, the presence of 
diminished selenium levels in children with cystic fibrosis, has 
been confirmed by others. The question of supplementation has 
not yet been answered. 
Concluding ,we would like to underline the fact that each essential 
trace element has its own requirement, influenced by different 
metabolic pathways of excretion and absorption. For this reason we 
consider oral suppletion of trace element mixtures of fixed composi-
tion as generally inappropriate. 
The problems of children with Wilson's disease are mu~tiple. To 
evaluate the effect of the decoppering therapy in 4 children with 
Wilson's disease, we determined serial serum copper and zinc levels 
as well as 24 h urinary zinc and copper excretion during D-Penicil-
lamine therapy and after a challenge dose of D-P. It was then 
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clear that the urinary copper excretion, after an initial rise, 
gradually declined during treatment as did the serum level. The 
urinary zinc excretion increased further. Zinc depletion was 
suspected in one patient in whom we documented the clinical features 
of zinc deficiency.Lowering the dose of D-P alleviated the symptoms 
as the urinary zinc loss was decreased by 50 %.The copper excretion 
remained unchanged. Our data showed clearly that D-P alters the 
metabolism of copper and zinc .This phenomenon is dose dependent and 
time related.We recommend that the dose of D-P during maintenan-
ce therapy should be adapted as to find an acceptable balance 
between copper accumulation and zinc depletion 
We also had the opportunity to investigate the effect of zinc-copper 
interaction for the treatment of Wilson's disease.It had already 
been shown in 1961 by Schouwink in Utrecht that pharmacological 
doses of zinc block the absorption of copper and thus prevent its 
accumulation in Wilson's disease. we evaluated the effect of oral 
zinc sulphate in 2 children with clinically stable Wilson's disease 
after completion of 3 years therapy .The clinical, biochemical and 
histological course was satisfactory in both patients.In one child 
the liver copper content fell.In the other child ,the liver copper 
content rose as did the 24 h copper excretion after a D-P challenge. 
we concluded that zinc sulphate is a well tolerated and low toxic 
alternative for D-P .The quantity of zinc required to block copper 
absorption adequately depends greatly on not yet well identified 
individual factors. Thus we recommend to restrict its use in 
patients who do not tolerate DP well .We suggested to monitor close-
ly this treatment with a D-P challenge every 12 months and a liver 
biopsy if liver function deteriorates. 
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Having been involved with trace elements metabolism in childhood and 
3 
infancy , we would like to conclude as Jonathan Shaw : 11 Perhaps the 
most remarkable fact about trace elements is not their scarcity but 
their abundance in the tissues of the hwnan body." 
When this work was started our knowledge of trace element require-
ments in infancy and childhood was not precise and still is After 
years of neglect ,however, progress has been achieved very recently 
with a growing appreciation of the proven and potential importance 
of these micronutrients.In the human ,the premature infant and the 
child with a malabsorption syndrome appear to be at a particular 
risk to develop such deficiencies. This is a period when substantial 
increases in total body content of trace elements occur and an 
additional demand is made on the limited quantities available .The 
gastrointestinal tract has at the same time a limited capacity to 
absorb some of the trace elements,while the 11 very" adapted formulas 
provide protein energy ,and other nutrients in abundance. 
We are thus confronted with one of the paradoxes of this society 
deficiency in the midst of opulence. 
l.H.A.Schroeder.In:Trace elements and nutrition. 10, London Faber 
and Faber,1976. 
2.L.Flohe.In:Trace metals in health and disease. Kharash N. (ed.) 
263 ,N.Y.:Raven Press , 1979. 
3.J.Shaw. Amer. J. Dis. Child. 133 :1260,1979. 
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SAMENVATTING 
Dit proefschrift bevat de beschrijving van enkele aspekten van het 
spoorelement metabolisme bij de zuigeling en het oudere kind. 
In hoofdstuk I worden de vragen die aan dit onderzoek ten grondslag 
liggen ingeleid,gevolgd door een kort overzicht van de litera-
tuurgegevens over selenium ,koper en zink.Ingegaan wordt op de 
aanbevolen hoeveelheden van deze micronutrienten , evenals op de 
faktoren die deze hoeveelheden kunnen beinvloeden. 
Hoofdstuk II bevat het onderzoek verricht naar de plasma selenium 
waarden en glutathion peroxidase aktiviteit in de rode bloedcellen 
als functie van de leeftijd. Bovendien wordt een beknopt overzicht 
gegeven van in de literatuur beschreven referentiewaarden van plasma 
koper en serum zink. Hieraan worden de eigen resultaten getoetst. 
In hoofdstuk III wordt de seleniumconcentratie beschreven,aanwezig 
in moedermelk ,geadapteerde koemelk of semi-synthetische voeding 
Tevens werd de concentratie spoorelementen in de gangbare 
oplossingen voor parenteraal gebruik bepaald.Het bleek dat in 
Belgie de gemiddelde hoeveelheid selenium die de zuigeling dagelijks 
via moedermelk krijgt, lager is dan in de meeste andere landen 
waarvoor gegevens bekend zijn. Dit geldt a fortiori voor 
geadapteerde koemelk en semi-synthetische voeding.Aansluitend werd 
het verloop van de selenium waarden in plasma en van de glutathion 
peroxidase aktiviteit bestudeerd in erythrocyten van zuigelingen, 
die langdurig parenteraal gevoed werden. 
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Hoofdstuk IV geeft de resultaten van een studie naar het metabolisme 
van selenium ,koper en zink bij 13 kinderen met pancreas fibrose 
Bij 2 patienten werd een verlaagd serum zinkgehalte gevonden ,moge-
lijk duidend op een marginale deficientie .De overige resultaten 
vielen binnen de norm .Daarentegen waren de koperwaarden verhoogd. 
De plasma seleniumwaarden waren significant lager dan de selenium-
spiegels van een qua leeftijd vergelijkbare controlegroep. 
Uit de in dit hoofdstuk gerapporteerde bevindingen werd onder meer 
geconcludeerd dat kant en klare spoorelementen mengsels niet altijd 
geschikt zijn als suppletie therapie bij malabsorptie syndromen, 
omdat ieder element gekenmerkt is door eigen absorptie- en elimi-
natiewegen . 
In hoofdstuk V.l valt de nadruk op de zink en koper huishouding 
tijdens D-Penicillamine therapie bij 4 kinderen met Morbus Wilson. 
Het werd duidelijk dat D-Penicillamine niet alleen de urineuit-
scheiding van koper bevordert , maar ook in belangrijke mate de 
zinkuitscheiding beinvloedt .Dit effect is afhankelijk van de dosis, 
maar ook van de reeds bereikte uitdrijving van het gestapelde koper. 
Op klinische en biochemische gronden werd bij een patient een 
zinkdeficientie vermoed. 
In hoofdstuk V.2 wordt ingegaan op de diverse aspecten van zink-
koper interaktie tijdens de behandeling van Morbus Wilson met zink-
sulfaat.Schouwink had reeds in 1961 in zijn proefschrift beschreven 
dat de koperabsorptie doeltreffend geremd wordt door pharmacolo-
gische doses zinksulfaat ,gegeven met de maaltijd .Men zou de accu-
mulatie van koper in de lever en andere weefsels bij patienten met 
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de ziekte van Wilson aldus kunnen voorkomen.Het klinisch,biochemisch 
en histologisch·verloop van beide in deze studie onderzochte patien-
ten , was ,na drie jaar behandeling met zink ,bevredigend. Bij een 
patient daalde het zinkgehalte in de lever ,terwijl een stijging bij 
het tweede kind werd waargenomen .Uit deze resultaten werd geconclu-
deerd dat zinksulfaat een aanvaardbaar en weinig toxisch alternatief 
middel is voor D-Penicillamine.Voorlopig is deze behandeling alleen 
gerechtvaardigd bij patienten die D-P slecht verdragen • De hoeveel-
heid zink die noodzakelijk is om de absorptie van koper adequaat te 
remmen is nl. sterk afhankelijk van onvoldoend bekende ,per individu 
verschillende , faktoren. 
Als algemene conclusie wordt in hoofstuk VI gesteld dat onze kennis 
over de behoeften aan spoorelementen van zuigelingen en kinderen 
vroeger weinig volledig was ,en ,ondanks grate vooruitgang , dit nog 
steeds is. 
Tenslotte wens ik te eindigen met het motto van Jonathan Shaw 
"Perhaps the most remarkable fact about trace elements is not their 
scarcity but their abundance in the tissues of the human body." 
(Amer.J.Dis.Child. 133:1260,1979.) 
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CURRICULUM VITAE 
De schrijfster van dit proefschrift werd in 1946 te Antwerpen 
geboren.Twee jaar later ,verhuisde ze naar het toenmalig Belgisch 
Kongo 
Heilig 
om in 1953 naar Brussel terug te keren.Zij bezocht Het 
Hart Lyceum te Antwerpen en behaalde in I963 het diploma 
uitgereikt door de Centrale eksamenkommissie te Brussel .In het-
zelfde jaar,begon zij de studie in de geneeskunde aan de Universi-
te Cat.~olique de Louvain. In 1970,legde zij het artsexamen af. 
Ze vertrok daarop naar Galveston,Texas,u.s.A. Aan de drie inten-
sieve opleidingsjaren als "House Officer 11 aan de U.T.M.B., heeft 
ze een buitengewone herinnering behouden.Aan Dr. C.W.Daeschner 
dankt zij haar interesse in voeding en spoorelementen onderzoek, 
aan Dr.J.Simon haar opleiding in algemene pediatrie, aan or. G. 
Powell haar specialisatie in pediatrische gastroenterologie ,aan 
Dr. A. Goldman haar verbijf in het Shriners Hospital for Crippled 
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specialiseren onder de leiding van Dr.C.Morin en Dr.C.Claude Roy. 
Dr.A.Weber ,model van een aktieve wetenschappelijke onderzoek-
ster,is voor haar neg belangrijker geweest dan het behalen van 
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In 1975, startte ze haar huidige loopbaan onder de leiding en 
hoede van Dr.J. Fernandes in het Sophia Kinderziekenhuis te 
Rotterdam (Hoofd:Prof.H.K.A.Visser). Bij hem leerde ze de basis-
methodologie van het klinisch wetenschappelijk onderzoek en tevens 
de weg naar het laboratorium.Aan Dr.H.Degenhart dankt zij het 
woord "selenium". 
In 1981 ,behaalde ze in Brussel het taaldiploma Nederlands, 
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tevens consulente kindergastroenterologie aan het 
Ziekenhuis te Antwerpen , en co-promotor van N.F.w.o. 
aan de Universitaire Instelling Antwerpen (U.I.A.). 
Algemeen 
) • Ze is 
Akademisch 
proj ekte...J. 
115 



